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Abstract
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientiﬁc
opinion re-evaluating the safety of propane-1,2-diol (E 1520) when used as a food additive. In 1996,
the Scientiﬁc Committee on Food (SCF) established an acceptable daily intake (ADI) of 25 mg/kg body
weight (bw) per day for propane-1,2-diol. Propane-1,2-diol is readily absorbed from the gastrointestinal
and is expected to be widely distributed to organs and tissues. The major route of metabolism is
oxidation to lactic acid and pyruvic acid. At high concentrations, free propane-1,2-diol is excreted in the
urine. No treatment-related effects were observed in subchronic toxicity studies. The available data did
not raise concern with respect to genotoxicity. Haematological changes suggestive of an increased red
blood cell destruction with a compensatory increased rate of haematopoiesis were observed at the
highest dose level (5,000 mg/kg bw per day) in a 2-year study in dogs. No adverse effects were
reported in a 2-year chronic study in rats with propane-1,2-diol (up to 2,500 mg/kg bw per day). The
SCF used this study to derive the ADI. No adverse effects were observed in the available reproductive
and developmental toxicity studies. Propane-1,2-diol (E 1520) is authorised according to Annex III in
some food additives, food ﬂavourings, enzymes and nutrients and it is then carried over to the ﬁnal
food. Dietary exposure to E 1520 was assessed based on the use levels and analytical data. The
Panel considered that for the food categories for which information was available, the exposure was
likely to be overestimated. Considering the toxicity database, the Panel concluded that there was no
reason to revise the current ADI of 25 mg/kg bw per day. The Panel also concluded that the mean and
the high exposure levels (P95) of the brand-loyal reﬁned exposure scenario did not exceed the ADI in
any of the population groups from the use of propane-1,2-diol (E 1520) at the reported use levels and
analytical results.
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Summary
Propane-1,2-diol (E 1520) is authorised as a food additive in the European Union (EU) according to
Regulation (EC) No 1333/2008 on food additives and speciﬁc purity criteria have been deﬁned in the
Commission Regulation (EU) No 231/2012.
In 1996, the Scientiﬁc Committee on Food (SCF) established an acceptable daily intake (ADI) of
25 mg/kg body weight (bw) per day for propane-1,2-diol.
In 1973, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) allocated an ADI of
0–25 mg/kg bw for propane-1,2-diol and in 2001 evaluated propane-1,2-diol as a food ﬂavouring;
however, the Committee did not ﬁnalise the evaluation as it wanted conﬁrmation that the substance is
actually used as food ﬂavouring. The Panel noted that propane-1,2-diol is not authorised as a
ﬂavouring substance in the EU according to Regulation 1334/2008.
Propane-1,2-diol is readily absorbed from the gastrointestinal tract in experimental animals and in
humans and is expected to be widely distributed to organs and tissues. The major route of metabolism
is oxidation to lactic acid and pyruvic acid. An alternative route of metabolism of propane-1,2-diol to
lactic acid is via phosphorylated glycol. At high concentrations, free propane-1,2-diol is excreted in the
urine as the elimination of propane-1,2-diol from the body is saturated at dose levels higher than
20,000 mg/day in humans. The renal clearance in young infants up to the age of approximately
3 months appeared to be much lower than in adults.
The acute oral toxicity of propane-1,2-diol was low.
No treatment-related effects were observed in subchronic toxicity studies in which 1,000 mg
propane-1,2-diol/kg bw per day was administered by gavage to mice, rats, dogs and monkeys for
92–97 days.
The Panel considered that the available data did not raise concern with respect to genotoxicity of
propane-1,2-diol.
Except for haematological changes suggestive of an increased red blood cell destruction with a
compensatory increased rate of haematopoiesis at the highest dose level (5,000 mg/kg bw per day),
no adverse effects were observed in a 2-year study in dogs administered propane-1,2-diol in the diet
(2,000 or 5,000 mg/kg bw per day). No adverse effects, including neoplastic ﬁndings, were reported in
a chronic study in rats administered propane-1,2-diol in the diet (up to 2,500 mg/kg bw per day) for
2 years. The SCF and JECFA used the study in rats to derive an ADI of 25 mg/kg bw per day using an
uncertainty factor of 100.
No adverse effects were observed in the available reproductive and developmental toxicity studies.
Propane-1,2-diol (E 1520) is authorised according to Annex III in some food additives, food
ﬂavourings, enzymes and nutrients and it is then carried over to the ﬁnal food. Dietary exposure to the
food additive was assessed based on data received by both industry (use levels) and Member States
(analytical data). In the reﬁned exposure assessment scenario, 20 food categories were taken into
account. Because propane-1,2-diol (E 1520) is authorised only according to Annex III, its labelling is
not mandatory, therefore, the Panel considered that the list of uses of this food additive from the
Mintel’s Global New Products Database (GNPD) was likely not exhaustive.
The exposure assessment was hampered by several uncertainties; overall the Panel considered that
for the food categories for which information was available, the exposure was likely to be
overestimated. The Panel considered that the brand-loyal scenario covering the general population was
the most appropriate scenario for risk characterisation of E 1520 assuming that the population is likely
to be exposed long-term to the food additive present at the maximum reported use in foods belonging
to the food category ‘Flavoured drinks’ and at the mean reported use/analytical data in foods
belonging to the other food categories. The highest high level of exposure (P95) to propane-1,2-diol
(E 1520) according to this scenario was estimated at 23.3 mg/kg bw per day in children.
The Panel also noted that propane-1,2-diol could be formed from metabolism of other food
additives (e.g. E 405, E 477). In this opinion, a combined exposure assessment was not performed.
Considering the overall toxicity database, the Panel concluded that there was no reason to revise
the current ADI of 25 mg/kg bw per day for propane-1,2-diol (E 1520).
The Panel also concluded that the mean and the high exposure levels (P95) of the brand-loyal
reﬁned exposure scenario did not exceed the ADI in any of the population groups from the use of
propane-1,2-diol (E 1520) as a food additive at the reported use levels and analytical results.
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The Panel recommended that:
• the European Commission considers lowering the current maximum limits for lead in the EU
speciﬁcation for propane-1,2-diol (E 1520) in order to ensure that propane-1,2-diol (E 1520) as
food additives will not be a signiﬁcant source of exposure to this toxic element in food.
• the European Commission considers inclusion of maximum limits for propylene oxide, mono-
and di-ethylene glycol and propylene carbonate in the EU speciﬁcations for propane-1,2-diol
(E 1520).
• the need for a combined exposure assessment to propane-1,2-diol from E 1520 and from
other food additives from which propane-1,2-diol is formed through metabolism should be
considered.
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1. Introduction
The present opinion document deals with the re-evaluation of propane-1,2-diol (E 1520) when used
as a food additive.
1.1. Background and Terms of Reference as provided by the European
Commission
1.1.1. Background
Regulation (EC) No 1333/20081 of the European Parliament and of the Council on food additives
requires that food additives are subject to a safety evaluation by the European Food Safety Authority
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food
additives must be kept under continuous observation and must be re-evaluated by EFSA.
For this purpose, a programme for the re-evaluation of food additives that were already permitted in
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/20102.
This Regulation also foresees that food additives are re-evaluated whenever necessary in light of
changing conditions of use and new scientiﬁc information. For efﬁciency and practical purposes, the
re-evaluation should, as far as possible, be conducted by group of food additives according to the main
functional class to which they belong.
The order of priorities for the re-evaluation of the currently approved food additives should be set
on the basis of the following criteria: the time since the last evaluation of a food additive by the
Scientiﬁc Committee on Food (SCF) or by EFSA, the availability of new scientiﬁc evidence, the extent
of use of a food additive in food and the human exposure to the food additive taking also into account
the outcome of the Report from the Commission on Dietary Food Additive Intake in the EU3 of 2001.
The report ‘Food additives in Europe 20004’ submitted by the Nordic Council of Ministers to the
Commission, provides additional information for the prioritisation of additives for re-evaluation. As
colours were among the ﬁrst additives to be evaluated, these food additives should be re-evaluated
with a highest priority.
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of
References are replaced by those below.
1.1.2. Terms of Reference
The Commission asks EFSA to re-evaluate the safety of food additives already permitted in the Union
before 2009 and to issue scientiﬁc opinions on these additives, taking especially into account the
priorities, procedures and deadlines that are enshrined in the Regulation (EU) No 257/2010 of 25 march
2010 setting up a programme for the re-evaluation of approved food additives in accordance with the
Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives.
1.2. Information on existing authorisations and evaluations
Propane-1,2-diol (E 1520) is an authorised food additive in the EU according to Annex III of
Regulation (EC) No 1333/2008 and speciﬁc purity criteria have been deﬁned in the Commission
Regulation (EU) No 231/20125.
The SCF evaluated several times propane-1,2-diol as a food additive (SCF, 1978, 1996, 1997), as a
solvent in food (SCF, 1981, 1996, 1997), as monomers and additives for food contact plastics (SCF,
1999). The Committee in its evaluation in 1981 concluded that there were sufﬁcient data available,
including long-term studies in rats and dogs, to establish an acceptable daily intake (ADI), and they
agreed with the ADI of 0–25 mg/kg body weight (bw) established by the Joint FAO/WHO Expert
1 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008, p. 16–33.
2 Commission Regulation (EU) No 257/2010 of 25 march 2010 setting up a programme for the re-evaluation of approved food
additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives.
OJ L 80, 26.3.2010, p. 19–27.
3 COM(2001) 542 ﬁnal.
4 Food Additives in Europe 2000, Status of safety assessments of food additives presently permitted in the EU, Nordic Council of
Ministers, TemaNord, 2002, 560.
5 Commission Regulation (EU) No 231/2012 of 9 march 2012 laying down speciﬁcations for food additives listed in Annexes II
and III to Regulation (EC) no 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012, p. 1–295.
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Committee on Food Additives (JECFA, 1974). In its evaluation in 1993 of propane-1,2-diol as a food
additive, the SCF noted an uncertainty with regard to potential mutagenic effects at the germ cell level,
which led the Committee to make the ADI temporary (but keeping the ﬁgure of 25 mg/kg bw per day)
(SCF, 1996). In 1996, the SCF evaluated new genotoxicity studies and although they did not entirely
correspond to the SCF’s request the Committee concluded nevertheless that the ADI of 25 mg/kg bw per
day could be reassigned to propane-1,2-diol (SCF, 1997).
In 1973, JECFA allocated an ADI of 0–25 mg/kg bw based on the level in rat and dog causing no
toxicological effect of 2,500 mg/kg bw and using an uncertainty factor of 100 (JECFA, 1974). In 2001,
JECFA evaluated propane-1,2-diol as a food ﬂavouring; however, the Committee did not ﬁnalise the
evaluation as it wanted conﬁrmation that the substance is actually used as food ﬂavouring (JECFA,
2002a,b). The Panel noted that propane-1,2-diol is not authorised as a ﬂavouring substance in the EU
according to Regulation 1334/2008.
Propane-1,2-diol (Ref. No 23740 and 81840) is included in the Union list of authorised substances
that may be intentionally used in the manufacture of plastic layers in plastic materials and articles
(Annex I to Commission Regulation (EU) No 10/20116).
The Scientiﬁc Committee for Animal Nutrition (SCAN) expressed a provisional opinion on the use of
propane-1,2-diol as a preservative in animal feed on the health of cats because of claims that when
the additive is fed to cats over a prolonged period of time, erythrocytes may develop oxidative damage
to the haemoglobin, Heinz body formation and, possibly, reduced resistance to oxidative stress. The
Committee concluded provisionally that there was no immediate need to suspend the use of the
substance in feed for cats (SCAN, 1991).
The EFSA Panel on Contaminants in the Food Chain (CONTAM) evaluated a list of substances,
including propylene glycol, in the Annex to Commission Directive 96/3/EC as acceptable previous
cargoes for edible fats and concluded that those would not be of health concern as previous cargoes
(EFSA CONTAM Panel, 2011).
The EFSA Panel on Biological Hazards (BIOHAZ) and the Panel on Food Contact Materials, Enzymes,
Flavourings and Processing Aids (CEF) evaluated the safety and efﬁcacy of a product, containing propane-
1,2-diol as a carrier, used for the removal of microbial surface contamination of raw poultry products. Both
Panels concluded that the potential exposure to propane-1,2-diol was several orders of magnitude below
the ADI and thus not of toxicological concern (EFSA BIOHAZ Panel and CEF Panel, 2012).
A working group established by the Nordic Council of Ministers concluded that there was no need
to re-evaluate propane-1,2-diol (E 1520), but a survey to estimate the likely exposure to the substance
was recommended. This recommendation was based on the fact that Danish control examinations
revealed levels of up to 28 g/kg in cakes (TemaNord, 2002).
The European Agency for the Evaluation of Medicinal Products (EMA) has evaluated the use of
propane-1,2-diol as a pharmacological active substance for animal uses and found it acceptable for ‘all
food producing species with no special conditions of use’ (EMA, 1996).
The Committee for Medicinal Products for Human Use (CHMP) considered the procedure under
Article 5(3) of Regulation (EC) No 726/2004 on the excipient, propylene glycol in medicines for
children as per questions posed (EMA, 2014a). In the ﬁnal document, EMA concluded ‘Nevertheless,
clinical data showed that in children from the age of 5 years and adult patients, up to 500 mg/kg/day
of propylene glycol could generally be considered safe. In the absence of compelling data this safety
threshold is decreased to 50 mg/kg/day in children less than 5 years old, and even to 1 mg/kg/day in
pre-term and term neonates due to known immaturity of both metabolic and renal clearances of
propylene glycol in these populations’ (EMA, 2014b).
Propane-1,2-diol is permitted in cosmetic products (European Commission database – CosIng7).
6 Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and articles intended to come into contact
with food. OJ L 12, 15.1.2011, p. 1.
7 Available online: http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction=search.simple
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2. Data and methodologies
2.1. Data
The Panel was not provided with a newly submitted dossier. EFSA launched public calls for data,8,9
to collect relevant information from interested parties.
The Panel based its assessment on information submitted to EFSA following the public calls for
data, information from previous evaluations and additional available literature up to February 2018.
Attempts were made at retrieving relevant original study reports on which previous evaluations or
reviews were based, however not always these were available to the Panel.
Food consumption data from the EFSA Comprehensive European Food Consumption Database
(Comprehensive Database10) was used to estimate the dietary exposure to propane-1,2-diol (E 1520).
The Mintel’s Global New Products Database (GNPD) was used to verify the use of propane-1,2-diol
(E 1520) in food products. Mintel’s GNPD is an online database that contains the compulsory
ingredient information present on the label of food products.
2.2. Methodologies
This opinion was formulated following the principles described in the EFSA Guidance on
transparency with regard to scientiﬁc aspects of risk assessment (EFSA Scientiﬁc Committee, 2009)
and following the relevant existing Guidances from the EFSA Scientiﬁc Committee.
The ANS Panel assessed the safety of propane-1,2-diol (E 1520) as a food additive in line with the
principles laid down in Regulation (EU) 257/2010 and the relevant guidance documents: Guidance on
submission for food additive evaluations by the SCF (2001).
When the test substance was administered in the feed or in the drinking water, but doses were not
explicitly reported by the authors as mg/kg bw per day based on actual feed or water consumption,
the daily intake was calculated by the Panel using the relevant default values as indicated in the EFSA
Scientiﬁc Committee Guidance document (EFSA Scientiﬁc Committee, 2012) for studies in rodents or,
in the case of other animal species, by JECFA (2000). In these cases, the daily intake is expressed as
‘equivalent’.
For this evaluation, the Panel used 1.036 g/cm3 (INRS, 2010) as a density for propane-1,2-diol.
Dietary exposure to propane-1,2-diol (E 1520) from its use as a food additive was estimated
combining food consumption data available within the EFSA Comprehensive Database with the
reported use levels and analytical data submitted to EFSA following a call for data. Different scenarios
were used to calculate exposure (see Section 3.3.1). Uncertainties on the exposure assessment were
identiﬁed and discussed.
3. Assessment
3.1. Technical data
3.1.1. Identity of the substance
Propane-1,2-diol (E 1520) has as chemical formula C3H8O2 and a molecular weight 76.10 g/mol.
The substance exists under different enantiomeric forms. Table 1 shows the structural formulae and
chemical registry numbers of these different forms.
Table 1: Structural formulae of enantiomers and registry numbers of propane-1,2-diol
Name Structural formula CAS registry number(a) EC (EINECS) number(a)
(R)-()-1,2-Propanediol 4254-14-2 610-038-5
8 Call for scientiﬁc data on miscellaneous food additives permitted in EU and belonging to several functional classes. Published:
6 July 2012. Available online: http://www.efsa.europa.eu/sites/default/ﬁles/consultation/120706a.pdf
9 Call for food additives usage level and/or concentration data in food and beverages intended for human consumption.
Published: 12 October 2015. Available online: http://www.efsa.europa.eu/en/data/call/151012
10 Available online: http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb.htm
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According to Commission Regulation (EU) No 231/2012, the propane-1,2-diol (E 1520) has the
EINECS Number 200-338-0. According to the EC inventory, the EINECS number indicated in the EU
speciﬁcations for E 1520 refers to CAS 57-55-6 that corresponds to (R,S)-1,2-propanediol (Sciﬁnder,11
online). The Panel noted that the authorisation of the racemic ((R,S)-1,2-propanediol) is not clearly
stated in the EU speciﬁcations.
Synonyms: propylene glycol; a-propylene glycol; 1,2-dihydroxypropane; methyl ethylene glycol.
According to Commission Regulation (EU) No 231/2012, propane-1,2-diol (E 1520) is described as a
clear, colourless, hygroscopic, viscous liquid. It is soluble in water, ethanol and acetone.
Propane-1,2-diol has a melting point of 60°C, a boiling point of 186–190°C and the partition
coefﬁcient (octanol/water) (log Pow) is 0.912 (CEFIC, 2012 (Documentation provided to EFSA n. 2)).
3.1.2. Speciﬁcations
The speciﬁcations for propane-1,2-diol (E 1520) as deﬁned in the Commission Regulation (EU)
No 231/2012 and by JECFA (2006) are listed in Table 2.
Name Structural formula CAS registry number(a) EC (EINECS) number(a)
(S)-(+)-1,2-Propanediol 4254-15-3 610-030-0
(R,S)-1,2-propanediol 57-55-6 200-338-0
CAS: Chemical Abstracts Service; EINECS: European Inventory of Existing Chemical Substances.
(a): EC inventory available online: https://echa.europa.eu/information-on-chemicals/ec-inventory
Table 2: Speciﬁcations for propane-1,2-diol (E 1520) according to Commission Regulation (EU)
No 231/2012 and JECFA (2006)
Commission Regulation (EU)
No 231/2012
JECFA (2006)
Assay Content not less than 99.5% on the
anhydrous basis
Not less than 99.5% on the anhydrous basis
Description Clear, colourless, hygroscopic, viscous
liquid
Clear, colourless, hygroscopic, viscous liquid
Identiﬁcation
Solubility Soluble in water, ethanol and acetone Soluble in water, ethanol and acetone
Speciﬁc gravity
(20°C/20°C)
1.035–1.040 1.035–1.040
Refractive
index
[n]D
20: 1.431–1.433 –
Infrared
absorption
– The infrared spectrum of a potassium bromide dispersion
of the sample corresponds with the infrared spectrum
below [in the speciﬁcations]
Purity
Distillation 99.5% of the product distils between
185°C and 189°C. The remaining
0.5% consists mainly of dimers and
traces of trimers from propane-1,2-
diol
99% v/v distils between 185- and 189°C
Water Not more than 1.0% (Karl Fischer
method)
Not more than 1.0% (Karl Fischer)
Sulphated ash Not more than 0.07% Not more than 0.07%
11 SciFinder the choice for chemistry researchTM.
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The Panel noted that, according to the EU speciﬁcations for propane-1,2-diol (E 1520), lead, as an
impurity, is accepted up to a concentration of 2 mg/kg. Contamination at this level could have a
signiﬁcant impact on the exposure already close to the health-based guidance value or benchmark
doses (lower conﬁdence limits) established by EFSA (EFSA CONTAM Panel, 2010, 2012).
According to the literature (Fowles et al., 2013) and to the information on the manufacturing process
(see Section 3.1.3), some by products (mono- and di-ethylene glycol) might be formed next to residual
propylene oxide used as a starting material. The Panel noted that there are not maximum limits for
propylene oxide and mono- and di-ethylene glycol in the EU speciﬁcations for propane-1,2-diol (E 1520).
According to information from the literature (Holtbruegge et al. (2015), see Section 3.1.3),
propane-1,2-diol, which is intended to be used as a food additive, can be manufactured by using as a
raw material propylene carbonate, which may not be completely removed from the ﬁnal product,
propane-1,2-diol. The Panel noted that no maximum limits for propylene carbonate are set in EU
speciﬁcations for E 1520.
3.1.3. Manufacturing process
According to industry, propane-1,2-diol is made from propylene oxide by reaction with water. The
resulting mixture consisting of mono-, di- and tri-glycols is distilled to obtain puriﬁed propane-1,2-diol.
The product is in accordance with the requirements for the European Pharmacopoeia for use as a
pharmaceutical excipient, and for use in food, feed and personal care applications. The production
process does not utilise catalysts or solvents and the ﬁnal product does not contain any additive (e.g.
stabilisers, antioxidants) (CEFIC, 2012 (Documentation provided to EFSA n. 2)).
Holtbruegge et al. (2015) proposed an optimisation of the production method of high purity
propane-1,2-diol, patented by Buchanan et al. (2002), which is intended for various uses, including the
use as a food additive. After a transesteriﬁcation of propylene carbonate with methanol, where sodium
methoxide is used as a catalyst, a membrane-assisted reactive separation process is proposed.
According to this method, propane-1,2-diol is collected together with non-reacted propylene carbonate
and subsequently the two solvents are separated via distillation.
In the literature other methods for manufacturing of propane-1,2-diol are reported or proposed,
based on
• a liquid-phase high pressure reaction (600 atmospheres) of synthetic gas in the presence of a
rhodium cluster complex (ASTDR, 1997),
• an hydrogenolysis of glycerol by using various catalysts like: copper, nickel or noble metals
(Bozga et al., 2011), highly active copper/magnesia (magnesium oxide) catalysts (Pudi et al.,
2015) or a copper/zinc/magnesia catalyst (Mondal et al., 2017), chromium oxide, or ruthenium
or platinum/tungsten catalysts (Kutz et al., 2017),
• via fermentation of deoxy sugars (i.e. rhamnose) or other substrates by using Clostridia,
Enterobacteriaceae or yeasts (Tanaka et al., 2017; Kutz et al. (2017)).
The Panel noted that none of these methods is suitable for the production of the food additive
E 1520, without further puriﬁcation steps, as they yield propane-1,2-diol having a lower purity than
required in the EU speciﬁcations for E 1520.
3.1.4. Methods of analysis in food
An analytical enzymatic method for the determination of propane-1,2-diol in commercial food is
available (Hamano et al., 1984). The method is based on the extraction of propane-1,2-diol from the
Commission Regulation (EU)
No 231/2012
JECFA (2006)
Free acid – Add 3–6 drops of phenol red TS to 50 mL water, then
add 0.1N sodium hydroxide until solution remains red for
30 s. To this solution, add about 50 g of the sample
accurately weighed. Titrate with 0.01N sodium hydroxide
until the original red colour returns and remains for 15 s.
Not more than 1.67 mL of 0.01N sodium hydroxide are
consumed by a sample of 50.0 g
Lead Not more than 2 mg/kg Not more than 2 mg/kg
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food with deionised water followed by its oxidation by propylene glycol dehydrogenase from
Microcyclus eburneus. During this step, oxidised nicotinamide adenine dinucleotide (NAD+) is reduced
to NADH and the absorbance of the solution is measured at 340 nm. Recoveries ranged from 85% up
to 99%. The limit of detection (LOD) was equal to 2 mg/kg.
A gas chromatographic method with ﬂame ionisation detection method is also available for the
determination of propane-1,2-diol in beer, after extraction with ethyl acetate. The recovery rate of the
method was reported to be 88% and the LOD 0.73 mg/L (Williamson and Iverson, 1993).
Tandem mass spectrometry method has been used for identiﬁcation of propane-1,2-diol in ﬁsh.
The sample was homogenised with methanol. No performance criteria of the method were given
(Matusik et al., 1993).
A titrimetric analytical method for the determination of propane-1,2-diol in vanilla extract was also
described (AOAC, 2000). This method is only applicable when the vanilla extract contains high
amounts of the food additive.
Sagadykova et al. (2017) described a method for the determination of propane-1,2-diol in wines
using gas chromatography–mass spectrometry (GC/MS). According to this method, a solid-phase
microextraction of the semi-volatile constituents of wine prior to the ﬁnal injection to the GC–MS
apparatus is applied. A standard addition is used to skip the estimation of recovery rates and the LOD
is 2 mg/L. A similar approach for the determination of propane-1,2-diol in cheese was proposed by
Badertscher et al. (2017) where an esteriﬁcation with phenyl boronic acid preceded the injection into
GC–MS. The LOD in this case was reported to be below 1 mg/kg.
A high-performance liquid chromatography (HPLC) method for the determination of propane-1,
2-diol in spirits was proposed by Tanaka et al. (2017). In this case, the Cu(II) ions of the mobile phase
enable the determination of the substance via an UV-detector (at 250 nm) with a LOD of 0.1 mL/L.
3.1.5. Stability of the substance, and reaction and fate in food
According to the information provided by industry, propane-1,2-diol is hygroscopic and sensitive to
sunlight, air, oxidising agents, acids, bases and high temperatures. Partial oxidation in the presence of
oxygen may lead to the formation of aldehydes, ketones, acids and dioxolanes. When stored outside in
transparent plastic containers, the rate of degradation increases with temperature, the presence of
metals and/or exposure to sun (UV) light. It has been shown that no aldehydes, ketones, acids and
dioxolanes were formed from propane-1,2-diol in a stability test over 2 years when kept out of sunlight
and kept at a temperature not exceeding 40°C (CEFIC, 2012 (Documentation provided to EFSA n. 2)).
Hence, according to industry, it is generally recommended to store the product in approved, closed
containers at temperatures not exceeding 40°C.
According to industry (CEFIC, 2012 (Documentation provided to EFSA n. 2)), the stability of
propane-1,2-diol as such is representative for the stability of the substance in food because there is no
interaction of the substance with food components.
The Panel noted that, as propane-1,2-diol may be used in a variety of food, which can also be
heat-treated and/or stored in daylight, it is expected that the substance partially degrades.
3.2. Authorised uses and use levels
Propane-1,2-diol (E 1520) is not authorised to be added directly to food according to Annex II to
Regulation (EC) No 1333/2008 on food additives. Maximum levels of propane-1,2-diol (E 1520) in ﬁnal
foods (via carry-over from food improving agents or nutrients) have been deﬁned only in Annex III to
Regulation (EC) No 1333/2008 on food additives, as amended.
According to Annex III, Part 1 of Regulation (EC) No 1333/2008, propane-1,2-diol (E 1520) is
authorised as a carrier in food additives (colours, emulsiﬁers and anti-oxidants), with a maximum level
of 1,000 mg/kg in ﬁnal food. It is also authorised from all sources in foodstuffs up to 3,000 mg/kg
(individually or in combination with triethyl citrate (E 1505), glyceryl diacetate (E 1517) and glyceryl
triacetate (E 1518)); in the case of beverages, with the exception of cream liqueurs, the maximum
level of E 1520 is 1,000 mg/L from all sources.
According to Annex III, Part 3, propane-1,2-diol (E 1520) is authorised as a food additive, only as a
carrier, in food enzymes, at the maximum level of 500 g/kg in enzyme preparation and with a
maximum level from all sources in foodstuffs of 3,000 mg/kg (individually or in combination with
E 1505, E 1517 and E 1518). In the case of beverages, with the exception of cream liqueurs, the
maximum level of E 1520 is 1,000 mg/L from all sources.
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In addition, according to Annex III, Part 4, propane-1,2-diol (E 1520) is authorised in all ﬂavourings
individually or in combination with E 1505, E 1517 and E 1518 at the maximum level of 3,000 mg/kg
from all sources in foodstuffs as consumed, or as reconstituted according to the instructions of the
manufacturers. In the case of beverages, with the exception of cream liqueurs, the maximum level of
E 1520 is 1,000 mg/L from all sources.
In addition, according to Annex III, Part 5, Section A of Regulation (EC) No 1333/2008, propane-1,2-
diol (E 1520) is authorised as a carrier only, in all nutrients (except nutrients intended to be used in
foodstuffs for infants and young children listed in point 13.1 of Part E of Annex II) at maximum level of
1,000 mg/kg in ﬁnal food and with a maximum level for E 1518 and E 1520 from all sources in foodstuffs
of 3,000 mg/kg (individually or in combination with E 1505 and E 1517). In the case of beverages, with
the exception of cream liqueurs, the maximum level of E 1520 is 1,000 mg/L from all sources.
3.3. Exposure data
3.3.1. Reported use levels or data on analytical levels of propane-1,2-diol
Most food additives in the EU are authorised at a speciﬁc maximum permitted level (MPL).
However, a food additive may be used at a lower level than the MPL. Therefore, information on actual
use levels is required for performing a more realistic exposure assessment.
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission
Regulation (EU) No 257/2010 regarding the re-evaluation of approved food additives, EFSA issued a
public call12 for occurrence data (usage level and/or concentration data) on propane-1,2-diol (E 1520).
In response to this call, occurrence data on propane-1,2-diol (E 1520) were submitted to EFSA by both
industry and Member States.
Summarised data on reported use levels in foods provided by industry
Industry provided EFSA with data on use levels (n = 548) of propane-1,2-diol (E 1520) in foods for
22 food categories. The provided use levels were submitted by FoodDrinkEurope (FDE), the
International Chewing Gum Association (ICGA), Specialised Nutrition Europe (SNE), KR€UGER GmbH &
Co and Spanish Association of Postharvest Services and Processes (AGRUPOST). The majority of the
submitted data (n = 521) were for the food category ‘Edible ices’ (FC 03).
The Panel noted that two use levels referred to niche products. These products belonged to the
food categories ‘Decorations, coatings and ﬁllings’ (FC 05.4) and ‘Dietary foods for special medical
purposes’ (FC 13.2). These use level were not considered in the exposure assessment. For FC 05.4, a
use level referring to a widely used product was available, whereas FC 13.2 was not included in the
exposure assessment (see Section 3.3.3).
The Panel considered that the reported use levels refer to the level of propane-1,2-diol (E 1520) in ﬁnal
food from all sources in foodstuffs (as a carrier from food additives, enzymes, ﬂavouring and all nutrients).
Appendix A provides data on the use levels of propane-1,2-diol (E 1520) in foods as reported by
industry.
Summarised data on analytical results in food submitted by Member States
In total, 162 analytical results were reported to EFSA by four countries: the Czech Republic (n = 7),
Germany (n = 72), Denmark (n = 73) and Ireland (n = 10). These data were mainly for ﬂavourings or
essence and pastries and cakes covering four food categories. Foods were sampled between 2000 and
2016, and the majority of them (98%) were analysed the year that they were collected.
Around half of the analytical results on propane-1,2-diol (E 1520) were left-censored: either not
quantiﬁed (< limit of quantiﬁcation (LOQ)) in 62 samples, or not detected (< LOD) in 25 samples.
Complete information on the methods of analysis (e.g. validation) was not made available to EFSA,
but all samples were derived from accredited laboratories.
The Panel noted that eight analytical results were obtained via suspect sampling and were
therefore excluded from the exposure assessment.
In order to include recent analytical data in the exposure assessment, only samples sampled in the
last 10 years were included. Samples collected before 2008 (n = 39) were therefore also excluded
from further analysis.
12 http://www.efsa.europa.eu/sites/default/ﬁles/consultation/151012.pdf
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Overall, 115 analytical results were reported for propane-1,2-diol (E 1520) in four food categories
and in ﬂavourings.
Appendix B shows the analytical results of propane-1,2-diol (E 1520) in foods as reported by
Member States.
The Panel noted that the analytical data reported by Member States showed the presence of
propane-1,2-diol in three food categories for which no uses have been reported by the food
manufacturers out of the four food categories for which data were reported. This may relate to the
fact that E 1520 is not directly added to the food by the manufacturers, but carried over via uses of
food ingredients, such as some food additives, food ﬂavourings, enzymes and nutrients.
3.3.2. Summarised data extracted from the Mintel’s Global New Products
Database
The Mintel’s GNPD is an online database that monitors new introductions of packaged goods in the
market worldwide. It contains information of over 2.5 million food and beverage products of which more
than 900,000 are or have been available on the European food market. The Mintel’s GNPD started covering
EU’s food markets in 1996; currently, it contains data from 20 out of its 28 Member-States and Norway.13
For the purpose of this Scientiﬁc Opinion, the Mintel’s GNPD14 was used for checking the labelling
of food and beverage products and food supplements for propane-1,2-diol (E 1520) within the EU’s
food market as the database contains the compulsory ingredient information on the label.
As mentioned before, propane-1,2-diol (E 1520) is authorised according to Annex III in some food
additives, food ﬂavourings, enzymes and nutrients and it is then carried over to the ﬁnal food.
According to legislation, the labelling of food additives used as such is not mandatory. Despite this,
propane-1,2-diol (E 1520) was labelled on 278 products between January 2013 and January 2018 (456
products on any date) according to the Mintel’s GNPD.
The products labelled with the food additive were mainly cakes, pastries and sweet goods, and
baking ingredients and mixes.
Appendix C lists the percentage of the food products labelled with propane-1,2-diol (E 1520) out of
the total number of food products per food sub-category according to the Mintel’s GNPD food
classiﬁcation. The percentages ranged from less than 0.1% in many food sub-categories to 1.2% in
the Mintel’s GNPD food subcategory ‘Frozen desserts’. The average percentage of foods labelled to
contain propane-1,2-diol (E 1520) was 0.1%. However, since the labelling of propane-1,2-diol (E 1520)
is not mandatory, the information about the use of this food additive from the Mintel’s GNPD is very
likely not exhaustive. However, the data received from industry seem to be in agreement with the
foods labelled with propane-1,2-diol (E 1520) according to the Mintel’s GNPD.
3.3.3. Food consumption data used for exposure assessment
EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database) has been populated with national data on food consumption at a detailed level. Competent
authorities in the European countries provide EFSA with data on the level of food consumption by the
individual consumer from the most recent national dietary survey in their country (cf. Guidance of
EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a). Consumption surveys added in the Comprehensive database in 2015 were
also taken into account in this assessment.15
The food consumption data gathered by EFSA were collected by different methodologies and thus
direct country-to-country comparisons should be interpreted with caution. Depending on the food
category and the level of detail used for exposure calculations, uncertainties could be introduced owing
to possible subjects’ underreporting, and/or misreporting of the consumption amounts. Nevertheless,
the EFSA Comprehensive Database includes the currently best available food consumption data across
Europe.
Food consumption data from the following population groups were used for the exposure assessment:
infants, toddlers, children, adolescents, adults, and the elderly. For the present assessment, food
consumption data were available from 33 dietary surveys carried out in 19 European countries (Table 3).
13 Missing Bulgaria, Cyprus, Estonia, Latvia, Lithuania, Luxembourg, Malta and Slovenia.
14 http://www.gnpd.com/sinatra/home/ accessed on 10/01/2018.
15 Available online: http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb.htm
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Consumption records were codiﬁed according to the FoodEx classiﬁcation system (EFSA, 2011b).
Nomenclature from the FoodEx classiﬁcation system has been linked to the food categorisation system
(FCS) as presented in Annex II of Regulation (EC) No 1333/2008, part D to perform exposure
estimates. In practice, the FoodEx food codes were matched to the FCS food categories.
Food categories considered for the exposure assessment of propane-1,2-diol (E 1520)
As described in Section 3.2, propane-1,2-diol (E 1520) is not authorised to be added directly into
foods (no authorisation according to Annex II to Regulation No 1333/2008). Propane-1,2-diol (E 1520)
is only authorised in some food additives (colours, emulsiﬁers and antioxidants) or enzymes, ﬂavourings
and nutrients. As a result of this authorisation, the majority of foods and beverages, within a diet could
contain propane-1,2-diol (E 1520) via carry over. However, the available data received suggested that
only a few products out of the whole number of products on the European market contained propane-
1,2-diol (E 1520).
A regulatory maximum level exposure assessment scenario could be calculated by attributing to all
foods and cream liqueurs the MPL of 3,000 mg/kg and to beverages, except cream liqueurs, the MPL
of 1,000 mg/kg. However, this scenario would be very uncertain and would result in an unrealistically
high estimate of the exposure. Thus, the Panel considered that a regulatory maximum level exposure
assessment scenario would not provide useful information about the exposure to propane-1,2-diol
(E 1520) and decided to perform only a reﬁned exposure assessment scenario.
In the reﬁned exposure assessment scenario, only food categories for which data were made
available to EFSA (either from industry or from Member States), and for which consumption data were
available were included in the exposure assessment. The food categories, which were taken into
account, are described below (in ascending order of the FCS codes):
• 01.7.1 Unripened cheese excluding products falling in category 16,
• 01.8 Dairy analogues, including beverages whiteners,
• 03 Edible ices,
• 04.1 Unprocessed fruits and vegetables,16
• 04.2.6 Processed potato products,
• 05.1 Cocoa and chocolate products as covered by Directive 2000/36/EC,
• 05.2 Other confectionary including breath freshening microsweets,
• 05.3 Chewing gum,
Table 3: Population groups considered for the exposure estimates of propane-1,2-diol (E 1520)
Population Age range
Countries with food consumption surveys covering
more than 1 day
Infants From more than 12 weeks up to
and including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, UK
Toddlers(a) From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy,
Netherlands, Spain, UK
Children(b) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland,
France, Germany, Greece, Italy, Latvia, Netherlands, Spain,
Sweden, UK
Adolescents From 10 years up to and including
17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Netherlands, Spain, Sweden, UK
Adults From 18 years up to and including
64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands,
Romania, Spain, Sweden, UK
The elderly(b) From 65 years of age and older Austria, Belgium, Denmark, Finland, France, Germany,
Hungary, Ireland, Italy, Romania, Netherlands, Sweden, UK
(a): The term ‘toddlers’ in the EFSA Comprehensive Database corresponds to ‘young children’ in Regulations (EC) No 1333/2008
and (EU) No 609/2013.
(b): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
16 Information provided by industry: It is part of a food coating formulation. Fresh fruits and vegetables taken into account are:
citrus (all citrus fruits were included), apple, pears, melon, peach, pineapple, pomegranate, mango, avocado, berries, papaya,
potato.
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• 05.4 Decorations, coatings and ﬁllings, except fruit-based ﬁllings covered by category 4.2.4,
• 07.2 Fine bakery wares,
• 12.2.2 Seasonings and condiments,
• 12.5 Soups and broths,
• 12.6 Sauces,
• 14.1.4 Flavoured drinks,
• 14.1.5.2 Coffee, coffee and chicory extracts, tea, herbal- and fruit-infusions; coffee substitutes,
coffee mixes and mixes for ‘hot beverages’, Other than coffee, coffee extracts
• 14.2.2 Wine and other products deﬁned by Reg (EC) No 1234/2007, and alcohol-free
counterparts,
• 14.2.6 Spirits drinks as deﬁned in Reg (EC) No 110/2008, except cream liqueurs,
• 14.2.6 Spirits drinks as deﬁned in Reg (EC) No 110/2008, only cream liqueurs,
• 15.1 Potato-,cereal-, ﬂour- or starch-based snacks,
• 16 Desserts,
• 17.1 Food supplements supplied in a solid form including capsules and tablets and similar
forms, excluding chewable forms,
• 17.3 Food supplements supplied in a syrup-type or chewable form.
For three food categories, use levels were provided by industry but could not be taken into account
in the exposure assessment: FC 01.7.6 Cheese products, FC 13.2 Dietary foods for special medical
purposes, and FC 18 processed foods not covered by categories 1 to 17. For FC 01.7.6, no
consumption data were available in the EFSA Comprehensive database. The eating occasions
belonging to FCs 13.2 (and 13.3) and 18 have been reclassiﬁed under food categories in accordance
to their main ingredient, as food items belonging to these food categories may be very diverse and, in
addition, for FCs 13.2 and 13.3, there is very limited information on their consumption. The reported
use levels of E 1520 for FCs 13.2 and 18 (Appendix A) were not considered in the exposure
assessment.
Additionally, industry provided use levels for FCs 17.1 and 17.3: food supplements in solid, syrup-
type or chewable form. In the EFSA Comprehensive database, no information is provided on the form
of food supplements ingested. In the exposure assessment, all food supplements (including FC 17.2,
food supplements in liquid form) were therefore considered together.
The Panel noted that analytical data were provided on both artiﬁcial and natural ﬂavourings
(Appendix B). To take these data into account in an exposure assessment, information on the levels of
these ﬂavourings in each ﬂavoured food as well as a list of ﬂavoured foods would be needed. As this
information was not available, conservative assumptions would be needed to include these ﬂavourings
in the exposure assessment, which would result in unrealistically high estimates of exposure. The
Panel decided therefore not to use these data in the current exposure assessment of propane-1,2-diol
(E 1520). However, the Panel considered that the reported use levels and the available analytical data
on propane-1,2-diol (E 1520), included its use in ﬂavouring preparations.
For the reﬁned scenario, 20 food categories were taken into account. The exposure to propane-1,2-
diol (E 1520) via the ingestion of food supplements was assessed via a separate exposure scenario
and included the same food categories as the reﬁned scenario as well as the three food supplement
food categories (Appendix B).
3.4. Exposure estimates
3.4.1. Exposure to propane-1,2-diol (E 1520) from its use as a food additive
The Panel estimated the chronic dietary exposure to propane-1,2-diol (E 1520) for the following
population groups: infants, toddlers, children, adolescents, adults and the elderly. Dietary exposure to
propane-1,2-diol (E 1520) was calculated by multiplying concentrations of propane-1,2-diol (E 1520)
per food category (Appendix D) with their respective consumption amount per kilogram body weight
for each individual in the Comprehensive Database. The exposure per food category was subsequently
added to derive an individual total exposure per day. These exposure estimates were averaged over
the number of survey days, resulting in an individual average exposure per day for the survey period.
Dietary surveys with only one day per subject were excluded as they were considered as not adequate
to assess repeated exposure.
This was carried out for all individuals per survey and per population group, resulting in distributions
of individual exposure per survey and population group (Table 3). Based on these distributions, the
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mean and the 95th percentile of exposure were calculated per survey and per population group. The
95th percentile of exposure was only calculated for those population groups with a sufﬁciently large
sample size (EFSA, 2011a). Therefore, in the present assessment, the 95th percentile of exposure for
infants from Italy and for toddlers from Belgium, Italy and Spain was not estimated.
As described above, a regulatory exposure scenario was not estimated in the current opinion. Thus,
solely a reﬁned exposure assessment scenario to propane-1,2-diol (E 1520) was carried out by the
Panel based on reported use levels and analytical data. This scenario does not consider the
consumption of food supplements. This source of exposure was covered in an additional scenario
(food supplements consumers only scenario).
Reﬁned exposure assessment scenario
The reﬁned exposure assessment scenario of propane-1,2-diol (E 1520) was based on use levels
reported by food industry and analytical results reported by Member States. This exposure scenario
can consider only food categories for which these data were available to the Panel.
Appendix D summarises the concentration levels of propane-1,2-diol (E 1520) used in the reﬁned
exposure assessment scenario. Based on the available data set, the Panel calculated two reﬁned
exposure estimates based on two model populations:
• The brand-loyal consumer scenario: It was assumed that a consumer is exposed long-term to
propane-1,2-diol (E 1520) present at the maximum reported use/P95 of analytical level for one
food category. This exposure estimate is calculated as follows:
– Combining food consumption with the maximum of the reported use levels or the 95th
percentile of the analytical results, whichever was highest or available, for the main
contributing food category at the individual level.
– Using the mean of the typical reported use levels or the mean of analytical results,
whichever was highest or available, for the remaining food categories.
• The non-brand-loyal consumer scenario: It was assumed that a consumer is exposed long-
term to propane-1,2-diol (E 1520) present at the mean reported use/analytical levels in food.
This exposure estimate is calculated using the mean of the typical reported use levels or the
mean of analytical results for all food categories.
In the two reﬁned exposure assessment scenarios, the concentration levels considered by the
Panel were extracted from the whole dataset (i.e. reported use levels and analytical results). To
consider left-censored analytical data (i.e. analytical results < LOD or < LOQ), the substitution method
as recommended in the ‘Principles and Methods for the Risk Assessment of Chemicals in Food’ (WHO,
2009) and the EFSA scientiﬁc report ‘Management of left-censored data in dietary exposure assessment
of chemical substances’ (EFSA, 2010) was used. In the present opinion, analytical data below LOD or
LOQ were assigned half of LOD or LOQ, respectively (middle bound (MB)). Subsequently, per food
category, the mean or median, whichever is highest, MB concentration was calculated.
Appendix D summarised the concentration levels of propane-1,2-diol (E 1520) used in the reﬁned
exposure scenarios.
Food supplement consumers only exposure assessment scenario
Use levels for propane-1,2-diol (E 1520) were reported by food industry for FC 17: Food
supplements as deﬁned in Directive 2002/46/EC excluding food supplements for infants and young
children. As exposure via food supplements may deviate largely from that via food, and the number of
food supplement consumers may be low depending on populations and surveys, an extra exposure
scenario was calculated in order to reﬂect additional exposure to propane-1,2-diol (E 1520) from food
supplements compared to exposure to propane-1,2-diol (E 1520) excluding these sources. This
scenario was estimated assuming that consumers of food supplements were exposed to propane-1,2-
diol (E 1520) present at the maximum reported use levels in food supplements on a daily basis. For
the remaining food categories (20 categories), the mean/median of the typical reported use levels or
analytical results was used.
As FC 17 does not consider food supplements for infants and toddlers as deﬁned in the legislation,
exposure to propane-1,2-diol (E 1520) from food supplements were not estimated for these two
population groups.
This scenario included 23 food categories (Appendix D).
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Dietary exposure to propane-1,2-diol (E 1520)
Table 4 summarises the estimated exposure to propane-1,2-diol (E 1520) from its use as a food
additive in six population groups (Table 3), according to the different exposure scenarios. Detailed
results per population group and survey are presented in Appendix E.
In the brand-loyal scenario of the reﬁned estimated exposure scenario, the mean exposure to
propane-1,2-diol (E 1520) from its use as a food additive ranged from 0.2 mg/kg bw per day in infants
to 11.6 mg/kg bw per day in toddlers. The high exposure to propane-1,2-diol (E 1520) ranged from
0.4 mg/kg bw per day in infants to 23.3 mg/kg bw per day in children.
In the non-brand-loyal scenario, mean exposure to propane-1,2-diol (E 1520) from its use as a
food additive ranged from 0.1 mg/kg bw per day in infants to 8.4 mg/kg bw per day in toddlers. The
95th percentile of exposure to propane-1,2-diol (E 1520) ranged from 0.3 mg/kg bw per day in infants
to 16.4 mg/kg bw per day in toddlers.
The main contributing food categories from the reﬁned estimated exposure scenarios, both brand-loyal
and non-brand-loyal scenario were unprocessed fruit and vegetables and ﬁne bakery wares for infants; for
all the other population groups, main contributing food categories were ﬁne bakery wares and ﬂavoured
drinks (Appendix F).
In the food supplements consumers only scenario, mean exposure to propane-1,2-diol (E 1520)
from its use as a food additive ranged from 0.7 mg/kg bw per day for the elderly to 10.9 mg/kg bw
per day for children. The 95th percentile of exposure to propane-1,2-diol (E 1520) ranged between
1.7 mg/kg bw per day for the elderly to 14.2 mg/kg bw per day for children.
Uncertainty analysis
Uncertainties in the exposure assessment of propane-1,2-diol (E 1520) have been discussed above.
In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary
exposure assessment (EFSA, 2007), the following sources of uncertainties have been considered and
summarised in Table 5.
Table 4: Summary of dietary exposure to propane-1,2-diol (E 1520) from its use as a food additive
in the reﬁned exposure scenario in six population groups (minimum–maximum across the
dietary surveys in mg/kg bw per day)
Infants
(12 weeks–
11 months)
Toddlers
(12–35
months)
Children
(3–9
years)
Adolescents
(10–17
years)
Adults
(18–64
years)
The elderly
(≥ 65 years)
Reﬁned estimated exposure assessment scenario
Brand-loyal scenario
Mean 0.2–3.1 1.0–11.6 3.4–10.5 1.8–7.0 1.0–3.6 0.8–3.0
95th percentile 0.4–12.4 3.3–21.8 7.7–23.3 4.4–15.2 2.9–9.5 2.0–7.3
Non-brand-loyal scenario
Mean 0.1–1.5 0.4–8.4 1.8–7.8 1.3–5.3 0.7–2.4 0.5–1.2
95th percentile 0.3–5.7 1.2–16.4 5.4–15.3 3.8–10.7 1.8–6.6 1.3–2.9
Table 5: Qualitative evaluation of inﬂuence of uncertainties on the dietary exposure estimate
Sources of uncertainties Direction(a)
Consumption data: different methodologies/representativeness/underreporting/misreporting/no
portion size standard
+/–
Use of data from food consumption surveys covering only a few days to estimate high
percentiles (95th) long-term (chronic) exposure
+
Correspondence of reported use levels and analytical data to the food items in the EFSA
Comprehensive Database: uncertainties to which types of food the levels refer
+/–
Uncertainty in possible national differences in use levels of food categories +/–
Concentration data:
• use levels considered applicable to all foods within the entire food category
• analytical data not fully representative of foods on the EU market (coming from 4 MSs)
• reliability of the data set
+
+/–
–
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Propane-1,2-diol (E 1520) is only authorised as carrier according to Annex III to Regulation
No 1333/2008, and therefore has the potential to be present in the majority of the food and beverage
products.
Use levels of the food additive were made available by industry for 22 food categories. Member
States provided analytical data on four food categories and ﬂavourings.
The Panel noted that according to the Mintel’s GNPD, propane-1,2-diol (E 1520) was labelled in less
than 300 food products in the last 5 years. For ﬁve food subcategories that included foods that were
labelled with propane-1,2-diol (E 1520) according to the Mintel’s classiﬁcation (Appendix C), no data
(reported use levels or analytical data) were provided to EFSA and these food categories were
therefore not taken into account in the exposure assessment (Cider, Bread & Bread Products, Poultry
Products, Spoonable Yogurt and Fish Products). However, the number of foods labelled with the food
additive within these food sub-categories was very small: maximally 5 (Appendix C). On the other
hand, some foods for which data were provided were not found to be labelled in the Mintel’s GNPD
(cheese products). Furthermore, the percentage of foods per food sub-category labelled to contain
propane-1,2-diol (E 1520) was maximally 1.2% (Appendix C), as opposed to the assumption of 100%
labelled of the foods belonging to an authorised food category in the exposure assessment. Given that
propane-1,2-diol (E 1520) is authorised only according to Annex III and industry is not obliged to label
the additive, information from the Mintel’s GNPD is uncertain.
It should also be noted that the use of MB LOD/LOQ values (half of LOD or LOQ) in the exposure
assessment (Section 3.3.1) may have resulted in either an overestimation, where propane-1,2-diol
(E 1520) was not present, or underestimation, where the concentration was between the MB and
LOQ/LOD value, but the analytical method was not able to detect or quantify it. The Panel however
estimated that the possible under/overestimation would have been minor as only for three food
categories, analytical data were used in the reﬁned exposure assessment scenario.
The Panel considered that based on the data that could be used in the reﬁned exposure
assessment scenario (food categories for which information was available) the uncertainties identiﬁed
would result in an overestimation of the exposure to propane-1,2-diol (E 1520) from its use as a food
additive, according to Annex III, in European countries considered in the EFSA European database.
3.4.2. Exposure via other sources
Propane-1,2-diol is also used in cosmetic products. Propane-1,2-diol is used as humectant, solvent
and preservative in a wide range of medicinal products (EMA, 2014a).
Lactobacillus parabuchneri, one of the most frequent representatives of lactobacilli present in
cheese, and the closely related Lactobacillus buchneri were found to be produced propane-1,2-diol in
cheese (Badertscher et al., 2017).
Quantiﬁcation of exposure via these sources was not precisely known and therefore could not be
taken into account in this opinion.
The Panel noted that propane-1,2-diol could be formed from metabolism of other food additives
(e.g. E 405, E 477). In this opinion, a combined exposure assessment was not performed.
Sources of uncertainties Direction(a)
Food categories selected for the exposure assessment:
• exclusion of food categories due to missing FoodEx linkage (n = 3)
• 20 food categories taken into account in the reﬁned exposure assessment scenario
–
+/–
Reﬁned exposure assessment scenario:
• 3 FCs with levels coming from analytical data: use of middle-bound (MB) LOD/LOQ values
for left-censored data
• exposure calculations based on the maximum or mean levels (reported use from
industries or analytical data)
+/–
+/–
MS: Member State; FC: food category; LOD: limit of detection; LOQ: limit of quantiﬁcation.
(a): +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of
exposure.
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3.5. Biological and Toxicological data
Even though it was not speciﬁcally indicated, the Panel considered that the propane-1,2-diol tested
in the biological and toxicological studies considered for this opinion would appear to be in the racemic
form.
3.5.1. Absorption, distribution, metabolism and excretion
Animals
Rats
The absorption of propane-1,2-diol was investigated by injection of 10 mL/kg bw of a 10%
propane-1,2-diol solution (1,031 mg/kg bw) into intestinal loops (15 cm long), the stomach and the
colon, in several animal species (van Winkle, 1941a). A total number of 72 rats, 16 rabbits and 48 cats
were used for the experiments. Absorption of propane-1,2-diol was reported to be identical in rabbits
and cats showing a very rapid absorption within 30 min from jejunum followed by duodenum, colon,
and stomach. Propane-1,2-diol was reported to be absorbed more rapidly in rats where a complete
absorption from the jejunum occurred within 20–30 min, whereas in rabbits and cats the absorption
from jejunum was 91% after 1 h. In cats, absorption of propane-1,2-diol from the jejunum was found
to be dose-dependent (after injection of a 5%, 10%, 50% or 100% solution). At the lowest dose
(5%), 66.4% propane-1,2-diol was absorbed, whereas 49.4% was absorbed at the highest dose
(100%). After 1 h, similar absorption levels for propane-1,2-diol (88.2–95.2%) were noted at all doses.
In the same publication, the renal excretion of propane-1,2-diol was described in rats. For this
investigation, groups of ﬁve rats were given 5%, 10%, 15% or 20% propane-1,2-diol in the drinking
water for 1 week (equivalent to 6,216, 12,432, 18,648 or 24,864 mg propane-1,2-diol/kg bw per day);
thereafter, the propane-1,2-diol solutions were replaced by water (van Winkle, 1941a). After a normal
ﬂuid balance was obtained, the propane-1,2-diol treatment was repeated. Measurement of the
propylene concentration in the urine showed that, regardless of the concentration of propane-1,2-diol
in the drinking water, about one-third of the amount ingested was excreted unchanged in the urine;
the remaining two-thirds were, according to the authors, metabolised in the body.
The kinetics of propane-1,2-diol elimination and metabolism in vivo have been investigated in rats
(Morshed et al., 1988). Male Wistar rats (6 animals/group) were given a single oral dose of propane-
1,2-diol administered as an aqueous solution at concentrations of 4.83, 9.66, 19.32, 38.64 and
77.28 mmol/kg bw. The time required to reach the maximum concentration of propane-1,2-diol in
blood was linearly related to the dose (10, 20, 30, 60 and 90 min, respectively). The rate of
elimination of propane-1,2-diol from the blood was found to be a ﬁrst-order process. The plot of the
observed elimination velocity vs the propane-1,2-diol doses indicated that the elimination of propane-
1,2-diol from the body was saturated at the higher dose levels. Likewise, a linear increase in the
urinary excretion of propane-1,2-diol was observed for increasing doses (24-h urine samples) with only
1/5 of the administered dose of propane-1,2-diol being excreted within the 24-h period. According to
the authors, the maximal metabolising capacity in rats of 0.63 g/kg bw per hour was equivalent to
1.06 kg/day for an average 70-kg human.
Rabbits
Rabbits (2 animals) showed increased excretion of glucuronic acid in the urine (22% and 100%,
respectively, at 48 h after dosing) following administration of a single dose of 2.3 mL propane-1,2-diol/kg
bw (2.383 mg/kg bw) by oral gavage, indicating, according to the authors, that propane-1,2-diol was
conjugated to glucuronic acid and that the conjugate was excreted in the urine (Fellows et al., 1947).
The blood concentration of propane-1,2-diol in New Zealand White rabbits (four animals) reached
its maximum level 1 h after administration by gavage of 28.4% propane-1,2-diol (38.66 mmol/kg bw,
equal to 2,942 mg) as an aqueous solution (Morshed et al., 1991a).
Cats
Plasma levels of propane-1,2-diol were determined in two cats fed a 12% propane-1,2-diol diet
(equal to 1,600 mg/kg bw per day) (Christopher et al., 1989a). Plasma levels of propane-1,2-diol at
19.1 and 8.4 mM/L were reported at day 24 after introduction of the propane-1,2-diol diet.
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Dogs
A dose of 2, 8 or 12 mL/kg bw (2,072, 8,288 and 12,432 mg/kg bw) of propane-1,2-diol was
administered per dog (Lehman and Newman, 1937). For investigating absorption, the dose was given
by stomach tube as a 50% solution (v/v) in warm tap water. The dog dosed with 2,072 mg/kg bw,
received the same dose intravenously in addition to the oral dose. The dog dosed with 8,288 mg/kg
bw was a second time treated with the same dose, now under pentobarbital anaesthesia. A dose of
6 mL (6,216 mg/kg bw) was given into the in situ isolated stomach from an untreated dog. The
maximum blood propane-1,2-diol level was observed 30 min after administration of 2 mL/kg bw and
2–4 h after administration of 8 or 12 mL/kg bw. Forty-eight hours after administration, 12% of the
total dose was excreted in the urine at 2 mL/kg bw and 39% at 8 mL/kg bw; after administration of
12 mL/kg bw, 36% of the total dose was excreted in the urine after 24 h. As the blood concentration
time proﬁle was nearly identical in the dog dosed with 2,072 mg/kg bw orally and intravenously, the
author concluded that the absorption was rapid and nearly complete. As the maximum blood
concentration in the dog in which a dose of 6,216 mg/kg bw was given into the isolated stomach was
at the same level as in the blood of the dog having received 2,072 mg/kg bw, the authors concluded
that the absorption by the stomach was low. The Panel agreed with the interpretation of the results.
Plasma levels of propane-1,2-diol were determined in female dogs as a function of time after a
single dose of 5,000 mg/kg bw (Weil et al., 1971). Peak values were reached at 6–8 h after dosing
and levels at 12 h after dosing were approximately half those at 8 h.
Humans
Absorption of propane-1,2-diol in human was found to be slower than in dog, as illustrated by an
experiment in which three human subjects were given a single oral dose of 1 mL propane-1,2-diol/kg
bw (1,036 mg/kg bw) (68, 75 mL/subject) (Hanzlik et al., 1939a). The highest concentration of
propane-1,2-diol measured in blood was reached after 30 min and persisted for approximately 4 h
before they began to decline, indicating, according to the authors, ‘a delayed absorption keeping pace
with the elimination of propane-1,2-diol from the body’. Blood concentrations varied considerably
between individuals. About 20–25% was eliminated in the urine within 10 h.
The pharmacokinetic proﬁle of the substance was examined in a multiple oral-dosing study by Yu
et al. (1985). Propane-1,2-diol was the solvent for the anti-epileptic drug phenytoin given to
outpatients of a neurological clinic. With the phenytoin, the patients received 20.7 g propane-1,2-diol
three times daily for a minimum of 3 days (n = 16) or 41.4 g propane-1,2-diol twice daily for a period
of 3 days (n = 6). Propane-1,2-diol was rapidly absorbed from the gastrointestinal tract with maximum
plasma concentrations obtained within 1 h of dosing. The average serum half-life of propane-1,2-diol
was calculated to be 3.8 h (20.7 g, 3 times daily) and 4.1 h (41.4 g, 2 times daily), respectively. The
average apparent total body clearance was approximately 0.1 L/kg per hour. However, a signiﬁcant
variability in clearance rate among individuals was observed. The apparent volume of distribution was
approximately 0.5 L/kg.
In a study with intravenous administration of propane-1,2-diol (doses between 5.1 and 21 g/day)
to 6 patients, the mean clearance was 0.41 L/h per kg bw, and the volume of distribution 0.8 L/kg bw
(Speth et al., 1987). The difference in apparent clearance and apparent volume of distribution after
oral dosing as compared to intravenous dosing might be explained by the bioavailability but also by a
saturated excretion.
A population pharmacokinetic analysis of propane-1-2-diol was done on 372 plasma samples taken
from infants (1–11 samples per patient) between 20 min and 20.5 h after intravenous administration
of a drug: paracetamol (34), phenobarbital (25) and phenobarbital plus paracetamol (3), which was
dissolved in propane-1-2-diol (De Cock et al., 2013). Sixty-two preterm and term infants were involved
in the study, with a gestational age between 24 and 41 weeks at birth and an age between 1 and
82 days, weighing 630–3,980 g. The population value for the clearance was 0.0849 L/h, which is
extremely lower than the value for adults (8.64–23.4 L/h per 1.73 m2; Speth et al., 1987). Variability in
clearance was explained by body weight at birth. Volume of distribution was dependent on the current
body weight. For example, the volume of distribution of a neonate of 1 kg (0.23–0.40 L) was very
different compared with a neonate of 4 kg (1.69–3 L).
In a further analysis of their data, De Cock et al. (2014) found out that renal elimination increased
from 15% of total clearance after the ﬁrst dose to 25% of the total clearance, one day later by an
unknown mechanism. Compared to the renal clearance in adults which is 45% of the total clearance renal
clearance in newborn infants was low, indicating the not yet fully maturated renal function at this age.
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The metabolism of propane-1,2-diol has been reviewed by different authors (Ruddick, 1972; LaKind
et al., 1999) (Figure 1).
Overall, propane-1,2-diol is readily absorbed from the gastrointestinal tract in experimental animals
and in humans and is expected to be widely distributed to organs and tissues. The major route of
metabolism is oxidation to lactic acid and pyruvic acid. An alternative route of metabolism of propane-1,
2-diol to lactic acid is via phosphorylated glycol. Lactate may be metabolised via the citric acid cycle and
excreted as carbon dioxide via exhalation. At high concentrations, free propane-1,2-diol is excreted in
the urine as the metabolism of propane-1,2-diol is saturated at dose levels higher than 20,000 mg/day
in humans (Yu et al., 1985). The Panel noted that in premature infants and infants in the ﬁrst weeks of
life the clearance of propane-1,2-diol was extremely low (De Cock et al., 2014).
3.5.2. Acute toxicity
Mice
Groups of 10–20 mice were fasted overnight (18 h before treatment) before administration of a
single dose of 20.0, 22.5, 25.0 or 30.0 mL propane-1,2-diol/kg bw by stomach tube (Laug et al.,
1939). The LD50 value was calculated to be 23.9 mL propane-1,2-diol/kg bw (24,760 mg/kg bw).
Groups of at least four mice received a single oral dose of propane-1,2-diol (six dose levels, not
speciﬁed) (Latven and Molitor, 1939). The LD50 value was calculated to be 22.0 mL propane-1,2-diol/kg
bw (22,792 mg/kg bw).
Rats
A single dosage of 26,000, 31,200 or 36,400 mg propane-1,2-diol/kg bw was administered orally to
groups of rats (5 animals/group) (Weatherby and Haag, 1938). The LD50 value was calculated to be
33,500 mg/kg bw.
Groups of 9–10 rats were fasted overnight (18 h before treatment) before administration of a single
dose of 15.0, 17.5, 17.6, 18.6, 20.0, 21.4, 22.5, 22.6 or 25.0 mL propane-1,2-diol/kg bw by stomach
tube (Laug et al., 1939). The LD50 value was calculated to be 21.0 mL propane-1,2-diol/kg bw
(21,756 mg/kg bw).
Figure 1: Metabolism of propane-1,2-diol in mammals (re-produced from Ruddick (1972))
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Rats received a single dose of propane-1,2-diol (diluted in water) by stomach tube. In most cases,
10 rats/group were used and the maximal dosage was 50,000 mg propane-1,2-diol/kg bw (Smyth
et al., 1941). The LD50 value was calculated to be 26,380 mg propane-1,2-diol/kg bw.
Groups of ﬁve female rats received a single dose by gavage of 18.2, 27.7, 31.6, 50.4 or 57.2 mL
propane-1,2-diol/kg bw (Thomas et al., 1949). The LD50 value was reported to be 28 mL propane-1,2-
diol/kg bw (29,008 mg/kg bw).
Groups of female F344 rats (5/groups) received a single oral dose of propane-1,2-diol by gavage.
The LD50 value was reported to be 22,800 mg/kg bw (Clark et al., 1979). Acute haemorrhagic enteritis
together with adrenocortical haemorrhage and widespread lymphocyte depletion were observed at
23,500 mg propane-1,2-diol/kg bw.
Guinea pigs
Groups of 10 guinea pigs were fasted overnight (18 h before treatment) before administration of a
single dose of 15.0, 17.5, 20.0 or 22.5 mL propane-1,2-diol/kg bw by stomach tube (Laug et al.,
1939). The LD50 value was calculated to be 18.9 mL propane-1,2-diol/kg bw (19,580 mg/kg bw).
A single dose of propane-1,2-diol diluted in water was administered to guinea pigs by stomach
tube. In most cases, 10 animals/group were used and the maximal dosage was 50,000 mg propane-
1,2-diol/kg bw (Smyth et al., 1941). The LD50 value was calculated to be 18,350 mg/kg bw).
Rabbits
Groups of rabbits (2–9/group) were dosed with 15,750, 18,900, 19,950 or 21,000 mg propane-1,2-
diol/kg bw (Braun and Cartland, 1936). Deaths occurred within 18–36 h post-treatment and the
minimum lethal dose (MLD) of propane-1,2-diol was estimated to 20,000 mg propane-1,2-diol/kg bw.
Overall, the acute toxicity for propanediol-1,2-diol was low.
3.5.3. Short-term and subchronic toxicity
Mice
A group of CD1 mice (10 animals/sex) was given 1,000 mg propane-1,2-diol/kg bw per day dissolved
in distilled water by gavage for 92–93 days (Thackaberry et al., 2010). The study was performed in
accordance with the OECD guideline No 408 (limit test) and in compliance with good laboratory practice
(GLP). The control group was administered by gavage 20 mg/kg bw per day in distilled water of
hydroxypropyl methylcellulose. No differences in clinical observations, body weights, food consumption,
ophthalmology, electrocardiograms, clinical pathology (blood and urine) or absolute and relative organ
weights were found between the propane-1,2-diol group and the control group. No macroscopic or
histopathologic changes in any organs (full section) were observed compared to controls.
Rats
The effect of continuous administration of propane-1,2-diol in the drinking water was studied by
Seidenfeld and Hanzlik (1932). Groups of 5 rats (sex not speciﬁed) were given 1%, 2%, 5%, 10%,
25% or 50% solutions of propane-1,2-diol in water for 140 days (equal to 1,600, 3,680, 7,700 or
13,200 mg/kg bw per day for the 1%, 2%, 5% or 10% group, respectively). The majority of rats
receiving 25 or 50% propane-1,2-diol died by the end of day 6 or day 9, respectively; the animals
showed an average weight loss of 10–20 g/rat and the ﬂuid intake was less than 0.5 mL/rat. No
signiﬁcant changes in growth and body weight were found in animals given 1%, 2%, 5% or 10%
propane-1,2-diol solution, and no signiﬁcant pathological changes in the kidneys, heart, spleen and
liver were observed.
In a subchronic toxicity study, a group of six female rats was given a concentration of 3.58% propane-
1,2-diol (equivalent to 2,890 mg/kg bw per day) via the drinking water for 11 weeks (Holck, 1937).
During the experiment, one rat died (week 10). According to the authors, by the end of the study, a
signiﬁcant weight loss was observed for one rat and the remaining rats were beginning to lose weight.
The toxicity of propane-1,2-diol was studies in white growing rats by administration of the
substance in the drinking water (Weatherby and Haag, 1938). Groups of ﬁve male rats at weaning age
received concentrations of 0%, 0.1%, 0.3%, 1%, 3% or 10% propane-1,2-diol in their drinking water
for 100 days. Food and drink were allowed ad libitum. According to the authors, rats receiving 10%
propane-1,2-diol in their drinking water consumed from 9,600 to 15,800 mg propane-1,2-diol/kg bw
per day. During the ﬁrst 10 days of the experiment, a decrease in weight gain together with poor
physical conditions was observed for rats receiving 10% propane-1,2-diol compared to the other
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groups. After this period, the animals seemed to recover and increase in weight in the same way as
the control group. Two animals from the 10% propane-1,2-diol group and one animal from the 1%
propane-1,2-diol group died before study termination. No different microscopic changes were found in
organs for any of the groups receiving propane-1,2-diol when compared to the control group.
In rats (5 animals, sex not speciﬁed) given daily 10 mL propane-1,2-diol/kg bw (10,360 mg/kg bw
per day) by gavage for 15 weeks, no effect on the growth rate was observed compared to control rats
(van Winkle, 1941b).
Hanzlik et al. (1939a) investigated the toxicity of propane-1,2-diol in young growing rats in a
continued consumption study and in a paired feeding experiment. In the continued consumption study,
rats (5 rats/group) were fed for 24 weeks on a diet where 25%, 50%, 75% or 100% of the
carbohydrate in the diet was replaced with propane-1,2-diol. The group fed a carbohydrate-free,
100% propane-1,2-diol-substituted diet showed no weight gain and all rats died within about a month
from study initiation. Rats receiving a 75% propane-1,2-diol diet showed signiﬁcant reduced food
intake and impaired growth rate; all rats died within 14 weeks after study initiation. A reduced growth
rate and decreased food consumption was observed for groups given diets containing 25% or 50%
propane-1,2-diol (equal to 8,288 or 31,200 mg propane-1,2-diol/kg bw per day) though it was most
pronounced at the beginning of the study; no mortality occurred within 20 weeks. According to the
authors, the reduced initial growth rate observed in groups fed propane-1,2-diol diets may be caused
by a distaste of the diet due to the propane-1,2-diol content. To test this hypothesis, a paired feeding
experiment was performed where groups of 6 rats were fed a 25% carbohydrate reduced diet for
5 months. During this period, rats were dosed daily by gavage with propane-1,2-diol (equal to 12.8%
of total food intake the previous day, or 25% carbohydrate substitution) or water (control). Rats
administered propane-1,2-diol increased signiﬁcantly in body weight compared to controls, which,
according to the authors is due to a higher calorie intake from propane-1,2-diol and showed the lack
of any toxic effect of propane-1,2-diol.
In a study by van Winkle and Newman (1941), paired-fed rats (5 rats/group) received propane-1,
2-diol or water (control) daily by stomach tube for 127–163 days. Rats dosed with propane-1,2-diol
were kept on a 25% reduced carbohydrate diet and dosed with a caloric equivalent amount of
propane-1,2-diol (total propane-1,2-diol intake ranged from 92.4 to 135.4 mg). Propane-1,2-diol dosed
rats were found to grow more rapidly and showed an increased weight gain compared to the controls.
In addition, propane-1,2-diol was found to increase the concentration of liver glycogen with 2–7 times
(van Winkle and Newman, 1941).
Administration of 5% or 10% propane-1,2-diol (equivalent to 6,250 and 12,500 mg/kg bw per day)
in the drinking water to 10 male rats for 5 weeks resulted in signiﬁcantly decreased red blood cell count
(8–11%) (Vaille et al., 1971). A dose-related increase in the liver weight (relative/absolute 20/11% or
37/27%) and in blood glucose (39% or 78%) was reported in the 5% or 10% group respectively. No
histopathological (liver, spleen, kidneys, heart, pancreas, adrenal glands) changes were observed. The
Panel noted that the administered doses were high, the highest one being half of the LD50 value.
When CD rats (15/sex per group) were fed a diet containing 50,000 mg propane-1,2-diol/kg diet
(equivalent to 4,500 mg/kg bw per day) for 15 weeks, no effects on serum and urine parameters,
haematology or organ weights (brain, heart, liver, spleen, kidneys, adrenals, gonads, and pituitary)
were noted (Gaunt et al., 1972). No abnormalities were seen at necropsy.
Groups of male Wistar rats (6 animals/group) were orally dosed with 38.66 mM/kg bw of propane-
1,2-diol (294.23 mg/kg bw per day as 1 mL 28.4%/100 g aqueous solution) for 10, 20 or 30 days
(Morshed et al., 1991b). A control group received an equal volume of saline. No deaths were observed.
The animals were necropsied after the required dosing schedule was ﬁnished. The brush border
membrane (BBM) from the jejuno-ileum part of the intestine of the animals was prepared. Various
enzymes were measured and sucrose, maltase, alkaline phosphatase, gamma-glutamyl transpeptidase
(GGT) and leucine amino peptidase activity was increased in the BBM of propane-1,2-diol treated
animals when compared to controls. The absorption of nutrient was measured using the tissue
accumulation method (intestinal rings of the jejunum were prepared). Intestinal absorption of dextrose,
glycine, L-aspartic acid, L-lysine, and calcium was increased for treated groups dosed for 20 or 30 days.
In another study by Morshed and Nagpaul (1995) using the same dose levels as above, propane-
1,2-diol-dosed groups showed signiﬁcantly increased plasma concentrations of lactate (approx. 1.7- to
2-fold) and glucose (approx. 1.3- to 1.7-fold) for all treatment periods. No difference in pyruvate
concentrations between treated and control rats were found for any of the treatment periods. The
lactate/pyruvate ratio was signiﬁcantly increased compared to controls after 10 days (approx. 2-fold)
and 20 days (approx. 1.3-fold) of treatment. A signiﬁcant decrease in plasma glutathione
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concentration was reported after 10 days of dosing (approx. 1.6-fold), but was not signiﬁcantly
different from the control group after 20 or 30 days of dosing. In addition, propane-1,2-diol treatment
inﬂuenced the concentrations of several plasma enzymes; treated rats had signiﬁcantly decreased
glutamic-oxaloacetic transaminase (GOT) at day 10 (approx. 1.2 fold), signiﬁcantly increased GGT at
day 10–30 (approx. 1.7- to 1.8-fold) and signiﬁcantly decreased acid phosphatase at day 10–30
(approx. 1.3- to 1.4-fold) (ethanol/propane-1,2-diol as a substrate). According to the authors, the
changes in plasma glucose, glutathione, lactate/pyruvate ratio and plasma enzyme activities such GOT,
GGT and acid suggested a toxic potential of propane-1,2-diol. The Panel considered these changes to
be most likely adaptive and related to the metabolism of propane-1,2-diol to lactate and for a
proportion of this, to be metabolised via gluconeogenesis to glucose, and therefore not adverse. A
signiﬁcantly increased activity of intestinal alcohol dehydrogenase was reported after propane-1,2-diol
treatment for 10 (approx. 1.7/1.8-fold), 20 (approx. 2.2/2.6 fold) and 30 (approx. 2.7/3.1-fold) days.
Male Sprague–Dawley rats (n = 10) were fed a basal diet with propane-1,2-diol (250 mg/kg diet)
for 42 days (equivalent to 30 mg/kg bw per day) (El-Wahab and Moram, 2013). The control group
was fed the basal diet only. By the end of the study period, the animals were sacriﬁced, blood samples
were drawn for examination of haematological and blood biochemistry parameters, and the livers,
hearts and kidneys were weighed in order to calculate the relative organ weights. The group fed
propane-1,2-diol had a signiﬁcant higher total feed intake, whereas the body weight gain was
signiﬁcantly decreased (p < 0.05) compared to the control group. The mean growth rate for rats fed
propane-1,2-diol was –22.3% compared to +91% for control rats. No signiﬁcant difference in the
relative weights of the liver, kidneys or heart was found between the propane-1,2-diol group and the
control group. Signiﬁcant increases in alanine aminotransferase, aspartate aminotransferase and
alkaline phosphatase activities, as well as in bilirubin, urea, creatinine, total protein and albumin were
observed in comparison to the control group. Compared to the control group, the haemoglobin
concentration and total number of RBC were decreased by 21% and 41%, respectively, in the
propane-1,2-diol group. Finally, propane-1,2-diol treatment was reported to signiﬁcantly decrease the
activity of reduced glutathione and superoxide dismutase activities in the blood and liver, as well as to
decrease the glutathione-S-transferase activity in liver. The loss of body weight (–22.3%) of the
animals of the only dose tested is very difﬁcult to explain; animals should gain weight as was reported
for the control group (+91%). The Panel considered this study as not reliable for this assessment
because weight loss and liver toxicity was not observed in any of the other studies, in particular when
considering the low dose (30 mg/kg bw per day) administered to the animals.
Sprague–Dawley rats (10 animals/sex per group) were given 1,000 mg propane-1,2-diol/kg bw per
day dissolved in distilled water by gavage for 92–93 days (Thackaberry et al., 2010). The control group
was administered 20 mg hydroxypropyl methylcellulose/kg bw per day dissolved in distilled water by
daily gavage. The study was performed in accordance with the OECD guideline No. 408 (limit study)
and in compliance with GLP. No differences in clinical observations, body weights, food consumption,
ophthalmology, electrocardiograms, clinical pathology (blood and urine) or absolute and relative organ
weights were found between the propane-1,2-diol group and the control group. No macroscopic or
histopathological changes in any organs were observed compared to controls.
Rabbits
No effect on growth rate in young rabbits (sex not speciﬁed) was found when propane-1,2-diol was
administered daily by gavage (as a 20% aqueous solution) for 50 days in concentrations of 1,050
(n = 1), 2,100 (n = 2), 3,150 (n = 1), 4,200 (n = 4) and 8,400 (n = 3) mg/kg bw per day (Braun and
Cartland, 1936).
Rabbits (seven male animals, fauve de Bourgogne, body weight approximately 3.2 kg) were daily
administered with 0% or 5% propane-1,2-diol in their drinking water for 8 weeks (equal to 14.8 mL/day
per rabbit; calculated by the Panel to be 5,000 mg propane-1,2-diol/kg bw per day) (Vaille et al., 1971).
In contrary to what was reported in rats in the same publication, induction of hyperglycaemia was not
detected.
Dogs
Hanzlik et al. (1939a) studied the toxicity of propane-1,2-diol in individual dogs (sex not speciﬁed)
administered by repeated gastric dosing (intervals of dosing not further speciﬁed). The authors
concluded that six repeated doses of 1.5 mL/kg bw (1,554 mg/kg bw per day) (1 dog), four repeated
doses of 2.0 mL/kg bw per day (2,072 mg/kg bw per day) (1 dog) or two repeated doses of 10.0 mL/kg
bw (10,360 mg/kg bw per day) (1 dog) showed no evidence of toxicity.
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In a study carried out by Van Winkle and Newman (1941), propane-1,2-diol at a concentration of
5% (equal to 5,284 mg propane-1,2-diol/kg bw per day) was administered in the drinking water to a
group of four female dogs for 5–9 months. The animals received no other ﬂuid. They had access to
the propane-1,2-diol containing water for 1 h twice daily, thus insuring a higher blood glycol level than
if the dogs drank small quantities of the propane-1,2-diol containing water at frequent intervals. The
dogs had a normal growth rate and no histopathological changes or alteration in the liver and kidney
function (galactose excretion, uric acid excretion, rose bengal test, phenolsulfonphthalein test) were
found in propane-1,2-diol-treated dogs. An attempt was made to keep a second group of dogs on
10% propane-1,2-diol in the drinking water, but this concentration was shown to cause a threefold
increase of drinking water intake (hypertonic drinking water) and to result in coma. Dogs died of
marked central depression or from a subsequent pneumonia.
Beagle dogs (4 animals/sex) were given 1,000 mg propane-1,2-diol/kg bw per day dissolved in distilled
water by gavage for 95–97 days (Thackaberry et al., 2010). The control group was administered 20 mg/kg
bw per day of hydroxypropyl methylcellulose dissolved in distilled water by daily gavage. The study was
performed in accordance with the OECD guidelines No. 409 (limit test) and in compliance with GLP. No
differences in clinical observations, body weights, food consumption, ophthalmology, electrocardiograms,
clinical pathology (blood and urine) or absolute and relative organ weights were found between the
propane-1,2-diol treated group and the control group. No macroscopical or histopathological changes in
any organs were observed compared to controls.
Monkeys
Cynomolgus monkeys (4 animals/sex) were given 1,000 mg propane-1,2-diol/kg bw per day
dissolved in distilled water by gavage for 95–97 days (Thackaberry et al., 2010). The control group
was administered 20 mg/kg bw per day of hydroxypropyl methylcellulose dissolved in distilled water by
daily gavage. The study was performed in accordance with the OECD guidelines No. 409 (limit test)
and in compliance with GLP. No differences in clinical observations, body weights, food consumption,
ophthalmology, electrocardiograms, clinical pathology (blood and urine) or absolute and relative organ
weights were found between the propane-1,2-diol group and the control group. No macroscopical or
histopathological changes in any organs were observed compared to controls.
Cats
The Panel noted that several studies have been performed in cats ((Dow Chemical, 1979
(Documentation provided to EFSA n. 3); Christopher et al. (1989a,b, 1990); Hickman et al., 1990; Bauer
et al. (1992a,b)). The Panel decided not to use these studies because that as described by LaKind et al.
(1999) ‘cats do not possess the ability to generate the glucuronide metabolite of PG, a detoxiﬁcation
capacity that acts via enhancement of urinary excretion of this product. The PG glucuronide conjugate
represents a substantial fraction of the PG recovered from urine of several species other than cats. This
lack of conjugation potential in cats may serve to enhance effective concentrations of PG in the systemic
circulation, and thereby yield hematotoxicity in this species. For this reason, while cats were the most
sensitive species tested, they are not viewed as being the most predictive of human responses to PG’.
Overall, in the preguideline rat studies propane-1,2-diol administered in the diet or drinking water
resulted in reduced growth rate at very high dose levels only; no other effects were reported. No
differences in clinical observations, body weights, food consumption, ophthalmology, electrocardiograms,
clinical pathology (blood and urine), absolute and relative organ weights, or macroscopic or
histopathologic changes in any organs were observed in a recent guideline study (limit study) in which
propane-1,2-diol was administered by gavage (1,000 mg/kg bw per day by gavage) to mice, rats, dogs
and monkeys for 92–97 days (Thackaberry et al., 2010).
3.5.4. Genotoxicity
In vitro
Propane-1,2-diol was reported to be negative when tested in Salmonella/microsome test (McCann and
Ames, 1976). In a reverse mutation assay using Salmonella Typhimurium strains TA98, TA100, TA1535,
TA1537 and TA1538, propane-1,2-diol (1–10,000 lg/plate) was not mutagenic with or without metabolic
activation (Clark et al., 1979). In S. Typhimurium strain TA100, no mutagenic potential was observed for
propane-1,2-diol when tested in concentrations up to 1,000 lmol/plate with or without metabolic
activation (Stolzenberg and Hine, 1979). In another reverse mutation assay using S. Typhimurium strains
TA98, TA100, TA1535 and TA1537, propane-1,2-diol (230 lg/plate) was also negative with or without
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metabolic activation (Florin et al., 1980). Similarly, propane-1,2-diol showed no mutagenic potential
when tested in S. Typhimurium strains TA98 and TA100 with or without metabolic activation, or in
Bacillus subtilis rec without metabolic activation (Kawachi et al., 1980). No mutagenic potential of
propane-1,2-diol was found when tested in S. Typhimurium strains TA98, TA100, TA1535 and TA1537
without metabolic activation at concentrations from 5- to 300 lmol/plate (Pfeiffer and Dunkelberg,
1980). Similar results were obtained when propane-1,2-diol was tested in S. Typhimurium strains TA98,
TA100, TA1535 and TA1537 with or without metabolic activation at concentrations ranging from 100 to
10,000 lg/plate (Haworth et al., 1983). In addition, propane-1,2-diol was reported to be negative in the
Salmonella/microsome test using S. Typhimurium strains TA92, TA94, TA98, TA100, TA1535 and TA1537
(with and without metabolic activation) (Ishidate et al., 1984).
The Panel noted that propane-1,2-diol was not tested in TA102 or Escherichia coli WP2 tester
strains. However, since oxidising or cross-linking activities are not expected to occur, overall, the Panel,
considered the negative results observed as reliable.
Propane-1,2-diol was assessed for its capability to induce chromosomal aberrations in anaphase in
human embryonic lung cells (WI38) at concentrations of 0.001, 0.01 and 0.1 lg/mL only in the
absence of S9 metabolic activation and no cytogenetic effects were reported (Litton Bionetics, 1974
(Documentation provided to EFSA n. 10)). However, the Panel noted that the test on induction of
chromosomal aberrations in anaphase did not receive further validation and it is currently not
employed in genetic toxicology testing. In addition, the assay was only performed in the absence of
S9 metabolic activation. On this basis the results obtained are of limited relevance.
In the study by Kawachi et al. (1980), propane-1,2-diol was reported to be positive when tested for
chromosomal aberrations in hamster lung ﬁbroblasts without and with metabolic activation, but
negative for the induction of sister chromatid exchanges (SCEs). However, the Panel noted that the
study is poorly reported with no indication of concentrations employed, treatment conditions and
number of cells scored. On this basis, the results reported as a single table (with plus or minus signs)
were judged to be not reliable.
Propane-1,2-diol was reported to be positive in another chromosomal aberration test using a
Chinese hamster ﬁbroblast cell line following treatments only in the absence of metabolic activation
(Ishidate et al., 1984). The incidence of aberrations was 38% at the highest concentration tested
(32 mg/mL) which is above the range of physiological osmotic pressure values, indicating, according to
the authors, that the cells may have been affected by the osmotic pressure changes in the culture
medium. The Panel agreed with this conclusion and noted that the recommended concentration limits
indicated in the current OECD Guideline No 473 correspond to 2 mg/mL. On this basis, the results
were judged unreliable.
In the study by Sasaki et al. (1980), propane-1,2-diol was tested for the induction of micronuclei
and SCE’s in the absence of S9 metabolic activation in a human ﬁbroblastic cell line (HE2144) and in a
Chinese hamster ovary Don-6 cell line. Concentrations used were 3.8, 7.6 and 23 mg/mL for both
micronuclei and SCEs in the Don-6 cell line and 3.8 and 7.6 mg/mL for SCE’s in the human ﬁbroblast
HE2144 cell line. Negative results were observed for induction of micronuclei in both cell lines, whereas
slight increases for induction of SCEs up to 1.8- and 1.5-folds over the concurrent control were only
observed in the Chinese hamster ovary Don-6 cells at concentrations of 23 and 7.6 mg/mL,
respectively. This result was judged by the Panel to be of no biological relevance since obtained at
concentrations exceeding the limit of 2 mg/mL recommended in the current OECD Guideline No 473.
Overall, the Panel considered the outcome of this study as negative for both micronuclei and SCEs but
with limitations since the assays were only performed in the absence of S9 metabolic activation.
A chromosome aberration assay in peripheral blood human lymphocytes was conducted in
compliance with GLP principles (Huntingdon-Research-Centre, 1990 (Documentation provided to EFSA
n. 7)). Replicate cultures were treated with propane-1,2-diol in both the absence and presence of
S9 metabolic activation at concentrations of 476, 1,910 and 3,910 lg/mL corresponding to 6, 25 and
51 mM. Cultures were sampled at 24 and 42 h after initiation of treatment. No biologically relevant
induction of chromosomal aberrations were observed at any treatment series, though the two higher
concentrations assessed far exceeded the limit of 10 mM recommended in the current OECD Guideline
No 473. The Panel noted that the study was in compliance with the OECD Guideline No 473 applicable
at the time when the study was performed. However, compared to the current version of the OECD
Guideline No 473 (2014) there are some limitations (e.g. the length of treatment time in the presence
of S9 (2 h vs 3–6 h) and the absence of a short treatment (3 h) in the absence of S9 metabolic
activation, selection of the high concentration, number of cells scored). On this basis, the results of the
study were considered of limited reliability by the Panel.
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Propane-1,2-diol was tested in a Chinese hamster ovary cell line (CHO-K1) for induction of DNA
strand-breaks in the alkaline comet assay and for chromosomal damages in the micronucleus assay
both in the absence and presence of S9 metabolic activation at concentrations of 0, 25, 50, 75 and
100 mg/mL, corresponding to 316, 632, 948 and 1,300 mM (Aye et al., 2010). Concentration-related
and statistically signiﬁcant increases for both the induction of micronuclei and DNA strand breaks were
observed at all concentrations employed, with the exception of 25 mg/mL in the presence of metabolic
activation. However, the Panel noted that the concentrations used far exceeded the limit of 10 mM
recommended in the current OECD Guideline No. 473 (2014). Therefore, the results obtained were
considered by the Panel not reliable.
The genotoxicity of propane-1,2-diol has recently been assessed in mouse oocytes by an in vitro
comet assay. Meiosis II oocytes obtained from prepubescent (< 4 weeks old) female CD-1 mice and
exposed for 1–2 h to 5%, 7% or 15% propane-1,2-diol solutions corresponding to 50, 75 and 150 mg/mL
(Berthelot-Ricou et al., 2011). A signiﬁcant DNA damage was noted at the two higher concentrations
(7.5% or 15%) at both exposure durations, whereas no DNA damage was reported at 5% propane-1,2-
diol. However, the Panel noted that the concentrations used far exceeded the limit of 2 mg/mL
recommended in the current OECD Guideline for the in vitro genotoxicity assays (e.g. OECD Guideline No.
473 (2014), in vitro mammalian chromosome aberration assay, No. 476 in vitro mammalian cell gene
mutation tests using the Hprt and Xprt genes, No. 487 in vitro mammalian cell micronucleus test, No. 490
in vitro mammalian cell gene mutation tests using the thymidine kinase gene). On this basis, the results
obtained were considered by the Panel not reliable.
In vivo
Propane-1,2-diol has been investigated in a host-mediated assay in mice. ICR random-bred male
mice (10 animals, 25–30 g each, at each dose level) were administered propane-1,2-diol by oral
gavage in both acute (single dose) and subacute studies (once a day for 5 days) (Litton Bionetics,
1974 (Documentation provided to EFSA n. 10)). The dose levels were 30, 2,500 or 5,000 mg/kg bw.
The indicator organisms (S. Typhimurium strain TA1530 and G46 for detection of induction of reverse
mutation, and Saccharomyces cerevisiae strain D-3 for detection of mitotic recombination) were given
by intraperitoneal injection. The negative control was the vehicle (saline) and the positive control was
dimethyl nitrosamine (100 mg/kg) for Salmonella, and ethyl methane sulfonate (350 mg/kg) for
Saccharomyces. Propane-1,2-diol caused no signiﬁcantly increased mutant frequencies in Salmonella
strain TA1530 or in strain G46 except for the acute high dose level at which, according to the authors
of the study report, may have been a weak or a questionable positive result. Saccharomyces strain D3
produced increased recombinant frequencies in the acute treatment at the low and intermediate dose-
levels and at all dose levels in the subacute treatment. However, according to the author, the
recoveries of the indicator organism decreased with increasing dose-levels and in the subacute
treatment, they were severely depressed possibly due to cell lethality. In conclusion, the author stated
for the strain D3 that ‘data are difﬁcult to interpret and at the dose-levels used it appears that
compound may be recombinogenic’. The Panel agreed with this conclusion but noted that this assay
did not receive further validation and it does not belong to the assays recommended for regulatory
purposes (EFSA Scientiﬁc Committee, 2011). On this basis, the positive outcome obtained was
considered to be of low relevance.
Propane-1,2-diol has also been investigated in a cytogenetic assay in rats. Male Sprague–Dawley
rats (10–12 weeks old, 280–350 g) were administered propane-1,2-diol by oral gavage in both acute
(single dose, in total 59 animals) and subacute studies (once a day for 5 days, in total 18 animals)
(Litton Bionetics, 1974 (Documentation provided to EFSA n. 10)). The dose levels were 30, 2,500 or
5,000 mg/kg bw. The negative control was the vehicle (saline) and the positive control was triethylene
melamine (0.3 mg/kg bw). In the acute studies, animals were sacriﬁced 6, 24 and 48 h after dosing
and in the subacute treatment 6 h after the last dose. Bone marrow cells were used to prepare
cytogenetic slides following administration of colcemid at 4 mg/kg by intraperitoneal injection to
accumulate cells in metaphase before sacriﬁce of animals. Fifty metaphase spreads for animal were
scored for chromosomal aberration analyses. The mitotic indices were also evaluated by scoring 1,000
cells (mitotic and interphase cells) per animal to assess cytotoxicity. The result obtained showed no
relevant increases in chromosomal aberration at any dose level and sampling time employed. Slight
reduction of mitotic indices in the test substance treatment groups were also observed indicating that
the test compound reached the target organ. The Panel noted that although 50 metaphases per
animal were scored instead of 100–200 as recommended by latter OECD Guidelines TG 473 (1997,
2014), in consideration of the high dose applied (higher than the maximum recommended) and of the
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evidence of target cells exposure, the results of this study can be considered as relevant for
genotoxicity assessment in a weight of evidence (WoE) approach.
In addition, propane-1,2-diol has been investigated in a dominant lethal assay in rats. Male
random-bred rats (10 animals per group, 10–12 week old) were administered propane-1,2-diol by oral
gavage in both acute (single dose) and subacute studies (once a day for 5 days) (Litton Bionetics,
1974 (Documentation provided to EFSA n. 10)). The dose levels were 30, 2,500 or 5,000 mg/kg bw.
The negative control was the vehicle (saline) and the positive control was triethylene melamine
(0.3 mg/kg). Following treatment, the males were sequentially mated to 2 females per week for 8
weeks (7 weeks in the subacute study). Females were sacriﬁced at 14 days after separation from the
male and the uterus was examined for corpora lutea, early fetal deaths, late fetal deaths and total
implantations. According to the authors of the study report, propane-1,2-diol was considered to be
non-mutagenic in rats in the dominant lethal assay when using the dosages employed in this study.
The Panel agreed with this conclusion.
In a micronucleus test, propane-1,2-diol did not induce micronuclei in femoral bone marrow cells
from male ddY mice (6 animals/group) after a single i.p. injection of 2,500, 5,000, 10,000, 15,000 or
20,000 mg/kg bw propane-1,2-diol (Hayashi et al., 1988). At 15,000 mg/kg bw, 3/6 mice died, and at
a dose of 20,000 mg/kg bw all six mice died. The Panel noted that although 1,000 polychromatic
erythrocytes (PCEs) per animal were scored instead of 2,000–4,000 as recommended by latter OECD
Guidelines TG 474 (1997, 2014), in consideration of the high doses applied (higher than the maximum
recommended) and of the evidence of systemic toxicity in treated animals, the results of this study can
be considered as relevant for genotoxicity assessment in a WoE approach.
Overall, the Panel considered that the available data did not raise concern with respect to
genotoxicity of propane-1,2-diol when used as a food additive.
3.5.5. Chronic toxicity and carcinogenicity
Rats
Morris et al. (1942) examined the chronic oral toxicity of propane-1,2-diol in rats. Groups of 10 albino
rats (both sexes) were fed 2.45% or 4.9% propane-1,2-diol (equivalent to 1,230 or 2,450 mg/kg bw per
day) in the diet for two years. No difference in food intake, growth and survival rate (after the ﬁrst year)
was observed between propane-1,2-diol groups and the control group. Histopathological examination of
the lungs, heart, liver, spleen, kidneys, adrenals, testis, pancreas, stomach, intestines and lymph nodes
showed that propane-1,2-diol did not induce adverse effects, except for slight chronic liver damage
characterised by diffuse or centrilobular atrophy, bile duct proliferation and fatty degeneration.
In a study by Gaunt et al. (1972), groups of CD rats (30/sex per group) were fed on diets
containing 0, 6,250, 12,500, 25,000 or 50,000 mg propane-1,2-diol/kg diet (equivalent to 0, 312, 625,
1,250, or 2,500 mg/kg bw per day) for 2 years. Propane-1,2-diol was not found to inﬂuence mortality,
body weight gain, food consumption or cumulative death rate. Overall, feeding of propane-1,2-diol had
no effect on haematology, urinary cell excretion, the urine-concentrating ability of the kidneys, organ
weights, pathological ﬁndings or tumour incidence (brain, heart, liver, spleen, kidneys, adrenals,
gonads, stomach, small intestine, caecum, salivary gland, trachea, aorta, thymus, lymph nodes,
pituitary, urinary bladder, colon, rectum, pancreas, uterus, muscle). No carcinogenic potential was
observed up 2,500 mg/kg bw per day, the highest dose tested.
Dogs
Chronic toxicity of propane-1,2-diol was studied in dogs by Weil et al. (1971). Groups of Beagle
dogs (5/sex per group, 10–14 month old at study initiation) were fed diets containing 0, 2,000 (low
dose) or 5,000 (high dose) mg propane-1,2-diol/kg bw per day for 2 years. A signiﬁcantly higher diet
utilisation (% g weight change/g diet consumed) was observed for high-dose male dogs compared to
controls during the ﬁrst three months of the study. Treated female dogs (low or high dose of propane-
1,2-diol) had signiﬁcantly lower water intake than controls only after 1 and 2 months (approx.
2.3-fold), while no difference in water intake was observed between control and treated male dogs.
Propane-1,2-diol treatment did not affect differential leucocyte counts, erythrocyte fragility, urinary pH
and histopathological changes, alkaline phosphatase, bromsulfthalein retention, liver glycogen, blood
glucose, total liver lipids, metabolic rate of liver slices using propane-1,2-diol, activities of serum
glutamic-oxalacetic and glutamic-pyruvic transaminases, percentage of water in the liver, or liver
weights (absolute and relative). In the low-dose group, sporadically lower total leucocyte counts were
observed in males, and females had a lower level of liver triglyceride; these changes were not
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observed in the high-dose group. No difference in spleen weights was noted between control and
treated groups. High-dose females had a slightly increased absolute kidney weight; however, no
signiﬁcant change in relative kidney weight and kidney histopathology was noted for these animals.
After 23.5 months of treatment, the high-dose group showed decreased mean total erythrocyte count
(both sexes: males: 17%, females: 15%) and decreased haemoglobin (both sexes: M: 13%, F: 20%)
and haematocrit (females: 11%) values. After 23 months feeding in these groups, an increase in
percentages of nucleated erythrocytes (females: 4.5-fold), mean reticulocyte count (females: 2.5-fold)
and the degree of anisocytosis and poikilocytosis (both sexes: 0/5) was reported pointing to
destruction of erythrocytes accompanied by accelerated erythropoiesis in the bone marrow. In the
high-dose group, total bilirubin was statistically signiﬁcantly increased in males after 6 (1.7-fold) and
24 months (1.8-fold) (but not after 8, 12, 13 or 23 months) and in females after 6, 8, 12, 13, 23 and
24 months (1.5- to 1.8-fold) (no changes in van den Bergh direct and indirect bilirubin values were
reported at the end of the study). Furthermore, urine output was raised in males at 23 months
(2.4-fold) and in females at 6 (1.4-fold) and 12 (1.3-fold) months. Treated groups had higher serum
propane-1,2-diol levels than controls; values were below 0.1% (v/v) 24 h after the daily dose of
propane-1,2-diol except for one dog where a concentration of 0.2% (v/v) was reported. At study
termination, glucose metabolic rates (when glucose was used as substrate), were signiﬁcantly lower in
animals fed propane-1,2-diol although only statistically signiﬁcant for high-dose males (4 fold). Gross
and histopathological examination showed no treatment-related changes in propane-1,2-diol-treated
animals. A slight increase in bone-marrow activity in high-dose females was considered by the authors
to be physiological and not pathological (Weil et al., 1971). The Panel considered the 2,000 mg/kg bw
per day as the no observed adverse effect level (NOAEL) in the 2-year study in dogs.
Overall, no adverse effects, including neoplastic ﬁndings, were reported in a chronic study in rats
administered propane-1,2-diol in the diet at 2,500 mg/kg bw per day (the highest dose tested) (Gaunt
et al., 1972). No adverse effects were observed in a 2-year study in dogs administered propane-1,2-
diol in the diet (2,000 or 5,000 mg/kg bw per day), except for haematological changes suggestive of
an increased red blood cell destruction with a compensatory increased rate of haematopoiesis at the
highest dose level (5,000 mg/kg bw per day) (Weil et al., 1971). The Panel considered 2,000 mg/kg
bw per day in dogs as the NOAEL for this study.
3.5.6. Reproductive and developmental toxicity
Reproductive toxicity
Mice
Propane-1,2-diol was studied in a Reproductive Assessment by Continuous Breeding (RACB) in
CD-1 mice (NTP, 1985; Morrissey et al., 1989; Lamb et al., 1997). In the reproductive phase of
these assessment, the study contained a control (n = 40/sex per group) and three treatment levels
(n = 20/sex per group (0%, 1.0%, 2.5% and 5.0% propane-1,2-diol in drinking water equal to 0,
1,819, 4,796, and 10,118 mg propane-1,2-diol/kg bw per day). The mice were exposed for a 7-day
premating period, during the cohabitation period of 14 weeks, and 3 weeks after the cohabitation
period. No differences in the fertility index, mean numbers of litters per pair, mean numbers of live
pups per pair, mean numbers of live males/females per pair, proportion of pups born live, and sex of
pups born live were noted when compared to the control group.
Bolon et al. (1997) examined the ovaries from 10 mice of the afore mentioned study that had been
exposed to 5% propane-1,2-diol as gametes, during prenatal and postnatal development, and as
young adults were examined for differential ovarian follicle counts (small, growing and large antral
follicles). Propane-1,2-diol showed no effect on reproductive function in terms of follicle counts
compared to controls.
Rats
Propane-1,2-diol was used as a vehicle control in a study in rats by Sj€oberg et al. (1986). The
control group of six male SD rats (35 days old, weight 130–160 g) was administered daily the vehicle
propane-1,2-diol by gavage for 5 days. The daily volume given to each animal was 2 mL/kg bw per
day (2,072 mg propane-1,2-diol/kg bw per day). The animals were sacriﬁced on day 6 and one testis,
the ventral lobes of the prostate and the liver were removed, weighed and examined histologically.
The number of degenerated cells in 50 seminiferous tubular cross-sections per testis was counted and
the most advanced germ cell type present was recorded. In the propane-1,2-diol group, only
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occasional degenerated cells were observed with the majority (19%) having 1–3 degenerated cells per
tubular cross-section and only 1% having 4–10 degenerated cells per tubular cross-section. Most of
these cells were either in early meiotic prophase or undergoing meiotic divisions.
The reproductive toxicity in Sprague–Dawley rats by daily gavage (vehicle: water) of 1,000 mg
propane-1,2-diol/kg bw dissolved in distilled water was examined by Enright et al. (2010). The control
group was given 20 mg/kg bw hydroxypropyl methylcellulose dissolved in distilled water. The study
was performed in compliance with GLP. In the fertility study, female rats (22 animals/group, 9–11
weeks of age at initiation of dosing, weight 203–264 g) were dosed for 2 weeks before and during
mating (up to 3 weeks) and from gestation day (GD) 0–7; male rats (22 animals/group, weight
203–264 g) were dosed before mating (3 weeks), during mating (up to 3 weeks) and after mating
(3 weeks). Animals were observed twice daily during the dosing period, body weights and food
consumption were recorded at regular. Oestrous cyclicity was assessed in all females for 2 weeks
before initiation of dosing through the day of mating. Females were sacriﬁced on GD 14, the uterus
was examined to determine pregnancy status, corpora lutea and uterine implants were counted and
implants were classiﬁed as a live or dead fetus, or resorption (early or late), and a gross examination
of the thoracic and abdominal cavities was performed on all F0 females in all dose groups. Males were
sacriﬁced within 3 weeks after the completion of the mating phase and a gross examination of the
thoracic and abdominal cavities and reproductive organs was carried on all F0 males in all dose groups.
No treatment-related effects were observed on paternal or reproductive toxicity. The Panel considered
1,000 mg propane-1,2 diol/kg bw per day (the only dose tested) as the NOAEL for this study.
Developmental toxicity
Mice
Groups of pregnant mice (25 animals/group) were given by gavage propane-1,2-diol in distilled
water (10 mL/kg bw) at dose levels of 0, 16, 74.3, 345 or 1,600 mg/kg bw per day from GD 6 to 15
(FDRL, 1973 (Documentation provided to EFSA n. 5)). One dam in the 74.3 mg/kg bw per day dose
group died before term. No other maternal effects or differences in the number of implantation sites,
resorptions, fetal body weight, viability or external, skeletal or visceral abnormalities were apparent.
The NOAEL for this study was 1,600 mg propane-1,2-diol/kg bw per day, the highest dose tested.
In a developmental screening assay, timed-pregnant CD-1 mice (30 animals, 60 days old) dosed
daily with propane-1,2-diol (10,000 mg/kg bw per day) by oral gavage on GD 8–12 were examined
after sacriﬁce for maternal toxicity (number of pregnant dams, mortality and number of dams with
resorptions) and neonatal effects (number of live pups and pup weight on postnatal day 1 and 3). No
treatment-related maternal or developmental effects were observed (Kavlock et al., 1987).
In a developmental toxicity study, timed-pregnant female CD-1 mice (30 animals/group) were
dosed daily by gavage with 0.5, 5 or 10 mL propane-1,2-diol/kg bw (518, 5,180 and 10,360 mg
propane-1,2-diol/kg bw per day) on GD 6–15; the control group (30 animals) received water (Union
Carbide, 1993 (Documentation provided to EFSA n. 14)). The study was performed in accordance with
the OECD guideline No. 414 and in compliance with GLP. The dams of the mid- and high-dose groups
had an increase water consumption. No other treatment-related maternal or developmental effects
were reported.
Rats
Pregnant rats (20–24 animals/group) were given propane-1,2-diol dissolved in distilled water by
gavage at dose levels of concentrations of 0, 16, 74.3, 345 and 1,600 mg/kg bw per day from GD 6 to
15 (dose volume was 6.4, 1, 1, 2 and 6.4 mL/kg bw, respectively) (FDRL, 1973 (Documentation
provided to EFSA n. 5)). No treatment-related maternal effects or differences in the number of
implantation sites, resorptions, fetal body weight, viability or external and visceral abnormalities were
apparent. The number of fetuses with wavy ribs was increased in all groups treated with propane-1,2
diol compared to the control group; however, no dose relation was observed. The Panel considered the
highest dose tested, 1,600 mg propane-1,2-diol/kg bw per day, as the NOAEL.
The prenatal developmental toxicity in Sprague–Dawley rats by daily gavage (vehicle: water) of
1,000 mg propane-1,2-diol/kg bw per day was examined by Enright et al. (2010). The control group
was given 20 mg hydroxypropyl methylcellulose/kg bw per day. Mated female rats (22 animals/group;
11 weeks of age at initiation of dosing; weight 227–300 g) were dosed from GD 6-17. Clinical
observations were made daily and maternal body weights and food intake were recorded on regular
intervals. Dams were sacriﬁced on GD 21, the uterus was examined to determine pregnancy status,
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corpora lutea and uterine implants were counted and implants were classiﬁed as a live or dead fetus,
or resorption (early or late), and a gross examination of the thoracic and abdominal cavities was
performed on all F0 females in all dose groups. All fetuses were weighed, sexed and examined
externally, and then sacriﬁced. Approximately half of fetuses in each litter underwent a visceral
examination; the remaining half underwent a skeletal examination. No treatment-related effects were
observed on maternal or developmental toxicity. The Panel considered the only dose tested, 1,000 mg
propane-1,2 diol/kg bw per day, as the NOAEL for this study.
Hamsters
Pregnant hamsters (21–25 animals/group) were given propane-1,2-diol dissolved in distilled water
by gavage at dose levels of 0, 15.5, 72, 334.5 and 1,550 mg/kg bw per day from GD 6 to 10 (dose
volume was 6.4, 1, 1, 2 and 6.4 mL/kg bw, respectively) (FDRL, 1973 (Documentation provided to
EFSA n. 5)). No treatment-related differences in maternal toxicity and in the number of implantation
sites, resorptions, fetal body weight, and visceral and skeletal abnormalities. The number of dead
fetuses was increased in the high-dose group (1 in the control group vs 18 in the high-dose group;
however 16 dead fetuses were found in one litter) and the number of live fetuses accordingly
decreased. The authors concluded only that there were no effects on skeletal and visceral
abnormalities. No statistical analysis or conclusion on other study data were presented. As the
increased number of dead fetuses was mainly due to one litter, the Panel considered 1,550 mg
propane-diol/kg bw per day as the NOAEL for this study. However, the Panel considered this study as
having limited reliability.
Rabbits
Pregnant rabbits (11–13 animals/group) were given propane-1,2-diol in distilled water by gavage in
concentrations of 0, 12.3, 57.1, 267 or 1,230 mg/kg bw per day from GD 6 to 18 (dose volume was 5,
1, 1, 2 and 5 mL/kg bw, respectively) (FDRL, 1973 (Documentation provided to EFSA n. 5)). No
effects attributed to propane-1,2-diol were observed for maternal or developmental effects. The
Panel considered 1,230 mg propane-1,2-diol kg bw per day (the highest dose tested) as the NOAEL
for this study.
The prenatal developmental toxicity of propane-1,2 diol was examined in New Zealand White
rabbits by daily gavage of 1,000 mg propane-1,2-diol/kg bw per day; the control group was given 20
hydroxypropyl methylcellulose mg/kg bw per day (Enright et al., 2010). Mated female rabbits (20
animals/group, 5–6 months of age at initiation of dosing, weight 2.7–3.8 kg) were dosed on GD 7–19.
Clinical observations were made daily, maternal body weights, food consumption (visual inspection)
were measured regularly. Dams were sacriﬁced on GD 29, the uterus was examined to determine
pregnancy status, corpora lutea and uterine implants were counted and implants were classiﬁed as a
live or dead fetus, or resorption (early or late), and a gross examination of the thoracic and abdominal
cavities and of the placenta was performed. All fetuses were weighed, sexed and examined externally,
and then sacriﬁced. All fetuses underwent a visceral and a skeletal examination. No differences in the
examined parameters between treated and control animals were reported. The Panel considered the
only dose tested, 1,000 mg propane-1,2-diol/kg bw per day, as the NOAEL for this study.
Overall, no adverse effects on reproductive toxicity parameters of propane-1,2-diol up to 5% (equal
to 10,118 mg propane-1,2-diol/kg bw per day) in drinking water were observed in a continuous
breeding reproduction study in mice (Morrissey et al., 1989; Lamb et al., 1997) or in a fertility study in
male and female rats given propane-1,2-diol (1,000 mg/kg bw per day) daily by gavage (Enright et al.,
2010). No adverse maternal or developmental effects were observed in prenatal developmental toxicity
studies with mice, rats, hamsters and rabbits given propane-1,2-diol by oral gavage at dose levels up
to 1,600, 1,600, 1,550 and 1,230 mg/kg bw per day, respectively, on GD 6–15, 6–15, 6–10 and 6–18,
respectively (FDRL 1973 (Documentation provided to EFSA n. 5)). In an additional developmental
toxicity study in mice, no adverse effect was observed in pregnant females dosed daily by gavage from
GD 6 to 15 up to 10,360 mg propane-1,2-diol/kg bw per day (Union Carbide, 1993 (Documentation
provided to EFSA n. 14)). In other prenatal developmental toxicity studies by gavage of 1,000 mg/kg
bw per day (the only dose tested) from GD 6 to 17 in rats or in rabbits from GD 7 to 19 (Enright et al.,
2010), no effects were observed.
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3.5.7. Hypersensitivity, allergenicity and food intolerance
There is a controversy about the contact allergenic potential of propane-1,2-diol in patch tests.
However, this seemed to be due to its low irritant potency, which often confounds the interpretation of
skin sensitisation reaction (Fowles et al., 2013; Jacob et al., 2017; Mc Gowan et al., 2017). The
Cosmetic Ingredient Review (CIR) did not report any sensitising potential or immunotoxicity for
propane-1,2-diol when used in cosmetics (CIR, 2011), and the EFSA CONTAM Panel did not consider
propane-1-2-diol as a possible allergen (EFSA CONTAM Panel, 2011). Given the large body of evidence
available, the Panel considered that it is very unlikely that propane 1-2-diol could be an allergen for
humans when used as a food additive.
3.5.8. Other studies
Young animals
C57BL/6 mice were exposed to a single intraperitoneal dose of propane-1-2-diol (dose range
1–10 mg/kg) to examine whether propane-1,2-diol could produce apoptosis in the developing central
nervous system (Lau et al., 2012). The investigation was performed in mice of different age (postnatal
day (PND) 4, 7, 14, 17, 24 and 30). Activated caspase-3 (Ac-3) was measured in the brain as this
seemed to be a sensitive measure of apoptosis. At 1 mL propane-1-2-diol (1,036 mg)/kg bw, there
was no signiﬁcant difference in Ac-3 cell counts between propane-1,2-diol treated cells and saline
animals. Compared to saline, 2 mL propane-1-2-diol (2,072 mg)/kg bw induced a statistically
signiﬁcantly, but less than 10% increase in the number of apoptotic neurons. The highest number of
propane-1,2-diol-induced apoptotic cells was measured when mice were exposed on PND 7. The
authors concluded that further research was needed to determine the underlying mechanism.
3.6. Discussion
Propane-1,2-diol was previously evaluated by the SCF and JECFA, and both committees established
an ADI of 25 mg/kg bw per day.
Some by products (mono- and di-ethylene glycol) might be formed next to residual propylene oxide
used as starting material. The Panel noted that there are not maximum limits for propylene oxide and
mono- and di-ethylene glycol in the EU speciﬁcations for propane-1,2-diol (E 1520). Additionally,
propane-1,2-diol can be manufactured by using as a raw material propylene carbonate, which may not
be completely removed from the ﬁnal product. The Panel noted that no maximum limits for propylene
carbonate are set in EU speciﬁcations for E 1520.
Propane-1,2-diol is readily absorbed from the gastrointestinal tract in experimental animals and in
humans and is expected to be widely distributed to organs and tissues. The major route of metabolism
is oxidation to lactic acid and pyruvic acid. An alternative route of metabolism of propane-1,2-diol to
lactic acid is via phosphorylated glycol. Lactate is mainly metabolised via the citric acid cycle and
excreted as carbon dioxide via exhalation. At high concentrations, free propane-1,2-diol is excreted in
the urine as the elimination of propane-1,2-diol from the body is saturated at dose levels higher than
20,000 mg/day in humans. The renal clearance in young infants up to the age of approx. 3 months
appeared to be much lower than in adults.
The acute oral toxicity of propane-1,2-diol was low.
No treatment-related effects were observed in subchronic toxicity studies in which propane-1,2-diol
was administered by gavage (1,000 mg/kg bw per day) to mice, rats, dogs and monkeys for 92–97 days
(Thackaberry et al., 2010).
The Panel considered that the available data did not raise concern with respect to genotoxicity of
propane-1,2-diol.
Except for haematological changes suggestive of an increased red blood cell destruction with a
compensatory increased rate of haematopoiesis at the highest dose level (5,000 mg/kg bw per day), no
adverse effects were observed in a 2-year study in dogs administered propane-1,2-diol in the diet
(2,000 or 5,000 mg/kg bw per day) (Weil et al., 1971). No adverse effects, including neoplastic
ﬁndings, were reported in a chronic study in rats administered propane-1,2-diol in the diet (up to
2,500 mg/kg bw per day) for 2 years (Gaunt et al., 1972). The SCF and JECFA used the study by Gaunt
et al. (1972) in rats to derive an ADI of 25 mg/kg bw per day using an uncertainty factor of 100.
No adverse effects on reproductive toxicity parameters of propane-1,2-diol up to 5% in drinking
water (equal to 10,118 mg propane-1,2-diol/kg bw per day) were observed in a continuous breeding
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reproduction study in mice (Morrissey et al., 1989; Lamb et al., 1997) or in a fertility study in male and
female rats given propane-1,2-diol (1,000 mg/kg bw per day) daily by gavage (Enright et al., 2010).
No adverse maternal or developmental effects were observed in prenatal developmental toxicity
studies with mice, rats, hamsters and rabbits given propane-1,2-diol by oral gavage at dose levels up
to 1,600, 1,600, 1,550 and 1,230 mg/kg bw per day, respectively, on GD 6–15, 6–15, 6–10 and 6–18,
respectively (FDRL 1973 (Documentation provided to EFSA n. 5)). In an additional developmental
toxicity study in mice, no adverse effect was observed in pregnant females dosed daily by gavage from
GD 6-15 up to 10,360 mg propane-1,2-diol/kg bw per day (Union Carbide, 1993 (Documentation
provided to EFSA n. 14)). In other prenatal developmental toxicity studies by gavage of 1,000 mg/kg
bw per day (the only dose tested) from GD 6 to 17 in rats or in rabbits from GD 7 to 19 no effects
were observed (Enright et al., 2010).
Based on the overall toxicity database, the Panel considered that there was no reason to revise the
current ADI of 25 mg/kg bw per day for propane-1,2-diol (E 1520).
Propane-1,2-diol (E 1520) is authorised according to Annex III in some food additives, food
ﬂavourings, enzymes and nutrients and it is then carried over to the ﬁnal food. Dietary exposure to the
food additive was assessed based on data received by both industry (use levels) and Member States
(analytical data). In the reﬁned exposure assessment scenario, 20 food categories were taken into
account. The data submitted to EFSA were consistent with information from the Mintel’s GNPD.
However, since the labelling of propane-1,2-diol (E 1520) is not mandatory, the information about the
use of this food additive from the Mintel’s GNPD is very likely not exhaustive.
The exposure assessment was hampered by several uncertainties (Table 5), overall the
Panel considered that for the food categories for which information was available, the exposure was
likely to be overestimated. For an elaborate discussion of the uncertainties, see Section 3.4.1. The
Panel considered that the brand-loyal scenario covering the general population was the most
appropriate scenario for risk characterisation of E 1520 as possible brand-loyalty to food belonging to
the food category ‘Flavoured drinks’ was identiﬁed. This scenario assumed that the population is likely
to be exposed long-term to the food additive present at the maximum reported use in foods belonging
to the food category ‘Flavoured drinks’ and at the mean reported use/analytical data in foods
belonging to the other food categories. The highest high level of exposure (P95) to propane-1,2-diol
(E 1520) according to this scenario was estimated at 23.3 mg/kg bw per day in children.
The Panel noted that the reﬁned exposure estimates are based on information provided on the
reported level of use of food additive (E 1520) and analytical data. If actual practice changes this
reﬁned estimates may no longer be representative and should be updated.
The Panel also noted that propane-1,2-diol could be formed during the metabolism of other food
additives (e.g. E 405, E 477). In this opinion, a combined exposure assessment was not performed.
4. Conclusions
Considering the overall toxicity database, the Panel concluded that there was no reason to revise
the current ADI of 25 mg/kg bw per day for propane-1,2-diol (E 1520).
The Panel concluded that the mean and the high exposure levels (P95) of the brand-loyal reﬁned
exposure scenario did not exceed the ADI in any of the population groups from the use of propane-
1,2-diol (E 1520) as a food additive at the reported use levels and analytical results.
5. Recommendations
The Panel recommended that:
1) the European Commission considers lowering the current maximum limits for lead in the EU
speciﬁcation for propane-1,2-diol (E 1520) in order to ensure that propane-1,2-diol (E 1520)
as food additives will not be a signiﬁcant source of exposure to this toxic element in food.
2) the European Commission considers inclusion of maximum limits for propylene oxide, mono-
and di-ethylene glycol, and propylene carbonate in the EU speciﬁcations for propane-1,2-diol
(E 1520).
3) the need for a combined exposure assessment to propane-1,2-diol from E 1520 and from
other food additives from which propane-1,2-diol is formed through metabolism should be
considered.
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Abbreviations
Ac-3 Activated caspase-3
ADI Acceptable daily intake
AGRUPOST Spanish Association of Postharvest Services and Processes
ANS EFSA Scientiﬁc Panel on Food Additives and Nutrient Sources added to Food
AOAC Association of Ofﬁcial Agricultural Chemists
AV Acid value
BBM Brush border membrane
BIOHAZ EFSA Panel on Biological Hazards
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bw Body weight
CAS Chemical Abstracts Service
CEF EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CEFIC EFSA Panel on Food Contact Material, Enzymes, Flavourings and Processing Aids
CHMP Committee for Medicinal Products for Human Use
CIR Cosmetic Ingredient Review
CONTAM EFSA Panel on Contaminants in Food Chain
EINECS European Inventory of Existing Chemical Substances
EMA European Agency for the Evaluation of Medicinal Products
FAO Food and Agriculture Organization of the United Nations
FCS Food categorisation system
FDE Food Drink Europe
GC–MS Gas chromatography–mass spectrometry
GD Gestation day
GGT Gamma-glutamyl transpeptidase
GLP Good laboratory practice
GOT Glutamic-oxaloacetic transaminase
GNPD Global New Products Database
HPLC High-performance liquid chromatography
ICGA International Chewing Gum Association
INRS Institut National fe Recherche et de Securite
JECFA Joint FAO/WHO Expert Committee on Food Additives
LD50 Lethal dose, median
LOD Limit of detection
LOQ Limit of quantiﬁcation
MB Middle-bound
MLD Minimum lethal dose
MPL Maximum permitted level
NAD+ Nicotinamide adenine dinucleotide
NOAEL No observed adverse effect level
OECD Organisation for Economic Co-operation and Development
PCE Polychromatic erythrocyte
PND Postnatal day
RACB Reproductive Assessment by Continuous Breeding
SCAN Scientiﬁc Committee for Animal Nutrition
SCE Sister chromatid exchange
SCF Scientiﬁc Committee on Food
SNE Specialised Nutrition Europe
TemaNord Is a publishing series for results of the often research-based work that working groups
or projects under Nordic Council of Ministers have put in motion
WHO World Health Organization
WoE weight of evidence
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Appendix A – Summary of reported use levels of propane-1,2-diol (E 1520)
provided by industry (mg/kg)
Appendix B – Summary of reported use levels of propane-1,2-diol (E 1520)
provided by Member States (mg/kg)
Appendix C – Number and percentage of food products labelled with
propane-1,2-diol (E 1520) out of the total number of food products
present in the Mintel GNPD per food sub-category between 2013 and 2018
Appendix D – Concentration levels of propane-1,2-diol (E 1520) used in
the reﬁned exposure assessment scenarios (mg/kg or mL/kg as
appropriate)
Appendix E – Summary of total estimated exposure of propane-1,2-diol
(E 1520) from its use as a food additive for the reﬁned exposure
assessment scenarios per population group and survey: mean and 95th
percentile (mg/kg bw per day)
Appendix F – Main food categories contributing to exposure to propane-
1,2-diol (E 1520) at the reﬁned exposure assessment scenarios (> 5% to
the total mean exposure)
Appendix A–F can be found in the online version of this output (‘Supporting information’ section).
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